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SUMMARY 
 
Consumer demands for fresh, microbiologically safe foods with high 
organoleptical and nutritional quality has led to the development of novel food 
preservation technologies as alternatives or enhancements to traditional 
preservation techniques.  An example of these novel preservation technologies 
is high hydrostatic pressure (HHP) processing.  It involves the applications of 
static pressure of 50 to 1 000 mega Pascals (MPa) to solid or packaged liquid 
foods, with varying holding times.  The combination of factors to enhance 
preservation is increasingly being used in industry, e.g. the use of different 
temperatures and additives (hurdles) can enhance the preservative effect of 
HHP.  In this study the influence of HHP on organism viability and growth 
response was assessed.  The organisms evaluated included Escherichia coli 
O111, Listeria monocytogenes (UAFSBCC) and Staphylococcus aureus (ATCC 
25923), in peptone water, which was subjected to HHP of 200 MPa for 15 
minutes at 8 and 50 ºC respectively.  Subsequent to the mentioned 
pressurisation, sub-culturing was performed and growth responses were 
evaluated at 0, 6, 18, 24, 30, 42 and 48 hours.  Bacterial survival and growth 
response was measured by means of intact cell count, colony forming units and 
optical density.  From the results it was eminent that bacterial cells were only 
sublethally injured and were able to repair within 48 hours of enriched sub-
culturing.  E. coli O111 proved to be most sensitive to HHP with Staphylococcus 
aureus (ATCC 25923) most resistant.  This study also proved that bacterial 
concentration and inactivation rate are inversely proportionate to each other.  
Subsequent to growth and cell repair assessments, E. coli O111 was selected 
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as a model to evaluate the effect of sublethal HHP on the liberation and toxicity 
of bacterial endotoxins (free and cell wall bound).  It is also known that different 
extraction procedures extract different lipopolysaccharides (LPS) fractions and 
therefore LPS was extracted from the test broth by a combination method of 
Folch, Lees & Sloane-Stanley, and Venter and Ivanov.  The extraction yielded a 
biphasic system, LPS with reduced lipid content in the upper phase (aqueous) 
and LPS with increased lipid content in the lower phase (organic).  Following 
extraction the Limulus amebocyte lysate (LAL) test was performed to quantify 
the concentration (assumed) of LPS in the aqueous and organic phases.  Free 
LPS was detected within six hours in the supernatant in the high and low 
bacterial loads, moreover the toxicity response of post HHP cell damage was 
more pronounced at 50 ºC (hurdle) than that observed for the treatments at 8 ºC 
(hurdle) and more so in the organic phases.  The latter implied that HHP not 
only resulted in quantity LPS variation but also in structural change.  However 
membrane repair was apparently complete after 48 hours, as differences in 
toxicity were no longer evident.  Furthermore, the use of a porcine IL-6 ELISA 
assay was evaluated as an alternative for the customary LAL as a biomarker for 
pyrogenic substances in matrixes.  Porcine whole blood was challenged for IL-6 
production by LPS in the samples from the organic and aqueous systems.  A 
porcine IL-6 enzyme-linked immunosorbent assay was used to assess IL-6 
expression in whole blood after being challenged with LPS.  From the results it 
emanated that HHP caused in a change in LPS structure which resulted in a 
decreased IL-6 expression in whole blood, indicating that structural adaptation 
of the cell membrane in response to HHP influenced the ability of LPS to 
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stimulate macrophages and monocytes.  Therefore, further research and 
development would be required to evaluate the influence of post HHP LPS on 
human IL-6 expression.  When comparing the porcine IL-6 with the LAL no 
correlation in toxicity could be established in any of the treatment parameters. 
 
Finally it can be concluded that HHP had an influence in the structural 
morphology of LPS.  These structural changes could result in LPS being more 
toxic, it could also have an effect on the accuracy of immunological 
assessments, the ability to form biofilm, and susceptibility to phages.   
 
KEYWORDS:  E. coli O111, Staphylococcus aureus, Listeria monocytogenes, 
LAL, IL-6, HHP, sublethal injury, endotoxin 
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CHAPTER 1 
 2 
1. INTRODUCTION 
Some of the most prevalent health problems encountered are the result of 
foodborne diseases, which influence the health of individuals and the development 
of societies (Schlundt, 2002).  A broad spectrum of microbial pathogens can 
contaminate food and water supplies and cause illness following ingestion of them 
or their toxins.  This causes a range of illnesses, where the invasive organism can 
produce clinical syndromes and toxins that can affect almost any system in the 
body.  Therefore, the term “foodborne disease” relates to many pathogens and 
many diseases (Tauxe, 2002).  The World Health Organization (WHO) defines 
food hazards as “biological, chemical, or physical agents in or property of food that 
may have an adverse health effect,” and food-related risks are traditionally defined 
as “a function of the probability of an adverse effect and the magnitude of that 
effect, consequential to a hazard in food” (WHO, 1995). 
 
Toxigenesis is an underlying mechanism by which many bacterial pathogens 
cause disease.  At a chemical level, there are two main types of toxins produced 
by bacteria.  Exotoxins secreted by Gram-positive bacteria, acts enzymatically or 
through direct action with host cells and stimulate a variety of host responses.  
Lipopolysaccharides, also known as endotoxins, are associated with the cell wall of 
Gram-negative bacteria and are liberated from bacterial cells upon death, division 
and as blebs (Todar 2008).  Lipopolysaccharides (LPS) are essential for the 
viability of Gram-negative bacteria.  Despite the wide variety of LPS expressed in 
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nature, they all have a common structure (Erridge, Benner-Guerrero & Poxton, 
2002).  Nevertheless, their structural details strongly influence their activity (Caroff 
& Karibian, 2003).  Differences between species and strains exist in LPS, and most 
variation occurs in the O-chain, followed by the core region and finally the lipid A 
moiety.  The endotoxicity of LPS is determined by the quantity, nature and 
arrangement of acyl chains and phosphate groups on lipid A, with 
lipopolysaccharide (LPS) structures displaying an acylation pattern similar to that of 
Escherichia coli (E. coli), being the ones optimally recognised by human 
monocytes (Erridge et al., 2002). 
 
LPS are among the most potent bacterial stimuli of the human immune system and 
are of great significance in the pathophysiology of many disease processes 
(Erridge et al., 2002; Proctor, Delinger & Bertics, 1995).  LPS induce the production 
of large amounts of inflammatory cytokines and mediators and provide numerous 
antigenic sites (Proctor et al., 1995).  LPS do not act directly against cells or 
organs, but through activation of the immune system, especially through 
monocytes and macrophages.  These cells release mediators such as tumour 
necrosis factor (TNF), interleukins and free radicals, having potent biological 
activity and being responsible for the adverse effects caused by LPS exposure 
(Martich, Boujoukos & Suffredini, 1993; Pabst & Johnston, 1989; Rietschel, Kirikae, 
Schade, Mamat et al., 1994).  In an infected host, small amounts of LPS can be 
protective by stimulating the immune system and have even been used to shrink 
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tumours.  Large amounts, however, have an adverse effect (Caroff & Karibian, 
2003). 
 
 
1.1 ORIGIN OF BACTERIAL LIPOPOLYSACCHARIDES 
Lipopolysaccharides were discovered in the eighteenth century during the search 
for a fever- and disease-producing substance that was associated with unclean 
conditions.  This substance was referred to as a pyrogenic substance, putrid 
poison, or toxin.  Richard Pfeiffer (1858-1945) identified the heat-stable substance 
produced by Gram-negative bacteria, and named it endotoxin (Rietschel & 
Westphal, 1999; Vaara & Nikaido, 1984).  The development of techniques for the 
extraction and preparation of endotoxins pure enough for structural elucidation was 
slow.  In the 1930s and 1940s it was reported that the structure consisted of a 
polysaccharide, a lipid part and a small amount of protein, hence the name 
lipopolysaccharide (Rietschel & Westphal, 1999).  In the 1950s, numerous 
techniques were developed for the extraction, purification and characterization of 
LPS, with further adaption and application of sugar and lipid chemistry to define the 
structure (Caroff, Karibian, Cavaillon & Haeffner-Cavaillon, 2002).  
 
LPS are an integral part of the outer membrane of Gram-negative bacteria and are 
responsible for the organisation and stability of the bacteria (Vaara & Nikaido, 
1984).  [See Figure 1.1 for the structure of the Gram-negative bacterial cell wall].  
LPS are anchored within the bacterial cell wall and are incessantly liberated into 
 5 
the environment when the cells die, during cell proliferation and division (Raetz, 
1990), and in the form of vesicles (Kuehn & Kesty, 2005).   
 
 
 
Figure 1.1 Structure of the Gram-negative bacterial cell wall (Varki, Cummings, 
Esko, Freeze, Stanley, Bertozzi, Hart & Etzler, 2009). 
 6 
1.2 LIPOPOLYSACCHARIDE ULTRA STRUCTURE 
With techniques such as high-performance liquid chromatography (HPLC), nuclear 
magnetic resonance (NMR) and epitope studies, the structure of the LPS of 
numerous Gram-negative bacteria have been elucidated and generally all conform 
to a common architecture.  [See Figure 1.2 for a schematic structure of E. coli 
O111:B4 LPS]. 
 
The basic structure for the LPS of Gram-negative bacteria comprises three distinct 
regions:  Lipid A, which is hydrophobic and the part responsible for the endotoxic 
activity;  the core, which is covalently attached to lipid A and which is divided into 
an inner and an outer core;  and a polymer of repeating subunits called the O-
polysaccharide (O-chain), which is attached to the core (Erridge et al., 2002).  
 
The core region close to lipid A and lipid A itself are partially phosphorylated;  
therefore, at neutrality, LPS exhibit a net negative charge (pKa=1.3) (Hou & 
Zaniewski, 1990).  The molar mass of an LPS monomer varies between 10 and 20 
kilo Dalton (kDA), owing to the variability of the oligosaccharide chain.  In some 
instances, masses of 2.5- (O-antigen-deficient) and 70 kDa (very long O- antigen) 
were found (Kastowsky, Gutberlet & Bradaczek, 1990). 
 
The three-dimensional structure of LPS, especially the long surface antigen, is 
more flexible than the globular structure of proteins (Kastowsky et al., 1990).   
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Figure 1.2 Schematic structure of E. coli O111:B4 LPS (Ohno & Morrison, 1989) 
(Hep = L-glycerol-D-manno-heptose; Gal = galactose; Glc = glucose; KDO = 2-
keto-3-deoxyoctonic acid; NGa = N-acetyl-galactosamine; NGc = N-acetyl-
glucosamine) 
 
 
Another characteristic is the formation of supramolecular structures, owing to non-
polar interactions between lipid chains, as well as to bridges generated among 
phosphate groups by divalent cations.  Hence, micellar structures and vesicles are 
produced that have much higher molar masses and diameters of up to 0.1 m, 
which, even in dilute aqueous solutions, show high stability levels (Anspach, 2001). 
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1.2.1 Lipid A 
The most conserved part of the LPS is lipid A, showing a narrow structural 
relationship between different bacterial genera (Hou & Zaniewski, 1990).  The lipid 
A of E. coli is composed of a -D-GlcN-(1-6)- -D-GlcN disaccharide carrying two 
phosphoryl groups at positions C-1 and C-4.  These phosphates can be substituted 
with groups such as ethanolamine, phosphate, ethanolamine phosphate, 
ethanolamine diphosphate, D-arabino-furanose, GlcN and 4-amino-4-deoxy-L-
arabino-pyranose (Moran, Lindner & Walsh, 1997).  Four primary (R)-3-
hydroxytetradecanoic acids are attached to this backbone by either ester (position 
3 and 3‟) or amide (positions 2 and 2‟) linkages.  In addition, two secondary acyl 
chains are found, tetradecanoic acid 14:0 ester linked to 14:0(3-OH) in position 3‟ 
and dodecanoic acid 12:0 linked to the hydroxyl group of the 14:0(3-OH) in amide 
linkage to position 2‟ (Gutsmann, Schromm & Brandenburg, 2007).  The acyl 
chains can be substituted by fatty acids to provide LPS with up to seven acyl 
substituents, which vary noticeably between species in nature, number, length, 
order and saturation.  The fatty acids can be attached to lipid A either 
asymmetrically (4+2, e.g. E. coli) or symmetrically (3+3, e.g. Neisseria 
meningitidis).  The most common fatty acids in lipid A have 10-16 carbon atoms, 
although longer chains do exist (Moran et al., 1997).  The number of fatty acid 
groups present in the LPS has a direct effect on its toxicity.  Fatty acid chain length 
is critical for lipid A toxicity since C12, C12OH, C14 and C14OH fatty acids are those 
found in the most toxic lipid A (Zähringer, Knirel, Lindner, Helbig et al., 1995).  
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Removal of a particular group of lipid A leads to a dramatic decrease in 
endotoxicity.  Cleavage of the acid-labile 1-phosphate (monophosphoryl lipid A) 
causes a reduction in cytokine production by one order of magnitude, and the 
removal of one acyl chain such as the secondary one in position 3‟ (pentaacyl lipid 
A) leads to a reduction by more than three orders of magnitude.  Upon removal of 
both secondary acyl chains (tetraacyl lipid A), there is a complete loss of activity.  
Changes in chemical primary structures lead to corresponding changes in the 
aggregate structures, i.e. to the molecular shape and to the intra-molecular 
conformation, which has a major influence on the biological activity (Gutsmann et 
al., 2007).  [See figure 1.3 for the structure of lipid A in E. coli]. 
 
The polysaccharide portion of the LPS is almost invariably linked to lipid A by 
means of a Kdo residue at position 6‟.  This portion of the molecule constitutes the 
most conserved region seen between LPS molecules: a phosphorylated 
diglucosamine backbone attached to at least one Kdo residue (Moran et al., 1997).  
[See figure 1.4 for the function of LpxA in lipid A biosynthesis]. 
 
 
1.2.2 Core Polysaccharide 
The O-polysaccharide region of the LPS can vary.  The oligosaccharide structures 
in the core part of the LPS are limited, with some regions being highly conserved 
between different strains and species.  The inner core is proximal to lipid A and 
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Figure 1.3 Structure of lipid A in E. coli (Raetz, Reynolds, Trent & Bishop, 2007) 
 
 
 
Figure 1.4 Function of LpxA in lipid A biosynthesis (Williams, Immormino, 
Gewirth & Raetz, 2006)   
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contains a large amount of unusual sugars such as L-glycerol-D-manno heptose 
(Hep) and 3-deoxy-D-manno-octulosonic acid (Kdo) (Erridge et al., 2002). Kdo is 
seen in almost every LPS, and is -bound to the carbohydrate backbone of lipid A.  
Exceptions to this have been seen with Acinetobacter and Burkholderia cepacia 
LPS, which employ the alternative 2-keto-D-glycero-D-talo-octonic acid (Ko) in its 
place.  The bond between the first Kdo residue and lipid A is acid labile, and with 
moderate pH (<4.4), easily hydrolysing the bond to release the core from lipid A.  
The Kdo residue is required for bacterial viability.  The outer core extends further 
from the surface of the bacteria and is more likely to consist of more common 
sugars such as glucose, galactose, N-acetyl galactosamine and N-acetyl 
glucosamine (hexose region).  The outer core is generally more variable than the 
inner core (Erridge et al., 2002). 
 
The extent of heterogeneity in the core of bacterial strains depends somewhat on 
the number of non-stoichiometric components present.  Non-stoichiometry is often 
attributed to incomplete biosynthesis, but could also be the result of partial 
degradation after complete biosynthesis (Caroff & Karibian, 2003).  “Phase 
variation” is another kind of core heterogeneity, which has been studied in the O-
chainless genera of Haemophilus, Neisseria, Campylobacter and other pathogens 
that invade mucosal tissues (Masoud, Martin, Thubault, Moxon & Richards, 2003; 
Moran & Prendergast, 2001).  Structural variations may have any of several types 
of genetic origin, one of which is replication slippage (Gilbert, Karwaski, 
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Bernatchez, Young et al., 2002).  The term “phase variation” applies to 
heterogeneities in bacterial cell surface components other than LPS cores.  The 
basis for this variation in Haemophilus and Neisseria is probably polymerase 
slippage during replication of short nucleotide repeats in genes encoding 
biosynthetic enzymes.  The reading frame on the deoxyribonucleic acid (DNA) is 
shifted and results in a switch-like change in the synthesis and addition of certain 
groups of sugars to a core (Cox, Wood, Martin, Makepeace et al., 2002).  The 
result of the modifications in the core structure is either the masking of an antigenic 
group (epitope) on the core or the mimicking of a host structure.  In both cases, the 
effect is a dulling of the potential reaction of the host (Preston & Maskell, 2002).  
Although the endotoxically active part of the molecule is lipid A, the nature and 
number of attached saccharide residues and substituents do have a considerable 
impact on modulating this activity (Erridge et al., 2002). 
 
 
1.2.3 Enteric Cores 
LPS cores typically consist of 8-12 branched sugar units.  The sugar at the 
reducing end is always -3-deoxy-D-manno-oct-2ulosonic acid (Kdo) (2 6)-linked 
to GlcNII of lipid A, and this bond is sensitive to mild-acid hydrolysis.  One or two 
Kdo groupings may be found at the C-4 position of Kdo.  Three L-glycero-D-manno-
heptose residues (L,D-Hep) are also (1 5) linked to the first Kdo.  A phosphate, 
pyrophosphate or phosphorylethanolamine group, or another sugar, may substitute 
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a heptose to make up the inner core, as is found in Shigella, Salmonella and 
Escherichia.  These substituents are often present in non-stoichiometric amounts 
(Holst, 1999).   
 
The outer LPS core of Shigella, Escherichia, Salmonella, Hafnia, Citrobacter and 
Erwinia generally consists of an oligosaccharide (up to six sugar units) (1 3)-
linked to HepII.  It is often branched with Gal, Glc or derivatives thereof.  However, 
there are exceptions found in the outer core:  E. coli K12 has a unit of L,D-Hep and 
strains of Klebsiella pneumoniae, which has one or two units of D-glycero-D-manno-
Heptose (D,D-Hep) linked to a Kdo unit serving as the attachment site of an O-chain 
(Vinogradov, Frirdich, MacLean, Perry et al., 2002; Vinogradov & Perry 2001). 
 
In the genus Proteus (vulgaris, penneri and mirabilis) the inner cores of almost all 
strains have their Kdo residue substituted at the C-8 position by 4-amino-4-deoxy-
-L-arabinose.  As for the rest, this part of the core resembles that of other enterics.  
The outer cores can, however, vary considerably.  Some of the unusual 
constituents include: a Kdo linked to Hep III, a GalA amide linked to an aliphatic 
amine or to the -amino group of L-lysine, 2-glycylamino-2-deoxy-D-glucose, the 
open-chain form of GalNAc glycosidically linked to GalN in the form of a cyclic 
acetal (Vinogradov, et al., 2002; Vinogradov & Perry, 2000; Vinogradov & 
Sidorczyk, 2002). 
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1.2.4 Non-Enteric Cores 
Hep, Kdo and hydroxytetradecanoic acid are considered to be identifying 
characteristics of LPS.  They are present in the LPS of wild-type enteric bacteria; 
however, it has been shown in mutants with shorter cores that these bacteria are 
able to survive under laboratory conditions without the heptose (Mäkelä & Stocker, 
1984).  Further research revealed that several non-enterics are devoid of heptose, 
and some had replaced Kdo with Ko.  A Neisseria meningitidis mutant lacking a 
core had been cultured and had been able to survive and grow slowly in a 
laboratory (Steeghs, Den Hartog, Den Boer, Zomer et al., 1998).  The core of the 
Francisella tularensis LPS has been reported to be entirely lacking heptose 
components.  The one Kdo unit present is linked to a -mannose-(1 4)- -
mannose disaccharide substituted at O-3 and O-2 by -Glc and -GalN-(1 2)- -
Glc, respectively (Vinogradov et al., 2002).   
 
The phosphate groups and charged sugar residues in the inner core and lipid A 
contribute to the stability of the outer membrane via cross-linking cations.  There 
are, however, variations in the number of negatively-charged components: one to 
three units of Kdo, the presence or absence of phosphate groups on lipid A, on 
Kdo and/or heptoses, and the presence or absence of an occasional hexuronic 
acid.  Due to the variability in the density of these charges in the lipid A inner core 
regions of different bacteria, the specific environmental conditions and the nature 
of bacterial capsules must be considered in explaining the diversities.  Bacterial 
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species are likely to have more O-chain types than core types (Amor, Heinrichs, 
Frirdich, Ziebell et al., 2000).  The inner cores of most LPS have Kdo and 
heptoses, but more diversified sugars are found in the outer cores of non-enteric 
bacteria.  The majority of sugars encountered in LPS are hexoses in the pyranose 
form. There are, however, exceptions, e.g. rhamnose found in some Pseudomonas 
aeruginosa strains, fructofuranose and sedoheptulofuranose in Vibrio cholerae, 
and 3-deoxy- -D-manno-oct-2-ulofuranosonic acid in Aeromonas salmonicida 
(Holst, 1999). 
 
 
1.2.5 O-Polysaccharide 
The O-polysaccharide (also referred to as O-chain or O-antigen) is the outermost 
part of the LPS and is the major antigen targeted by host antibody responses 
(Joiner, Grossman, Schmetz & Leive, 1986).  The repeating units of the O-
polysaccharide region consist of between one and eight glycosyl residues and vary 
between bacterial strains by means of the sugars, sequence, chemical linkage, 
substitution, and ring forms utilised.  There is a near limitless diversity of O-chain 
structures, which is verified in nature with the observation of hundreds of serotypes 
for particular Gram-negative species.  The number of subunits used to complete 
the chain varies between 0 and ~50, and a single bacterium can produce a wide 
range of these lengths as a result of incomplete synthesis of the chain.  This gives 
rise to the classical ladder pattern of molecular weights seen when smooth LPS is 
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visualised by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) (Erridge et al., 2002).  O-chain structures can be linear or branched and 
substituted by many different aglycones.  The most frequent substituents are O- 
and N-acetyl, phosphate and phosphorylethanolamine groups (Moran, Rietschel, 
Kosunen & Zahringer, 1991).  Amino acids in amide linkages, acetamidino groups 
and formyl groups, as well as glyceric acid, are often found as non-stoichiometric 
substituents (Janson, 1999).  Serology of the O-chain is a valuable diagnostic tool 
in typing bacterial strains and LPS.  The O-polysaccharide is recognised by the 
innate arm of the immune system, and plays a role in the activation and inhibition 
of complement activation (Joiner et al., 1986).  O-chains are typically composed of 
hexoses and are not ubiquitous, as they are truncated or lacking in a number of 
Gram-negative bacteria.  Bacteria that colonise mucosal surfaces often express 
LPS with a truncated non-repeating O-chain known as lipo-oligosaccharide (LOS).  
Certain strains also carry mutations in the otherwise well-conserved „rfb‟ locus 
(which contains a selection of genes involved in O-chain synthesis and attachment) 
and are termed “rough mutants” to differentiate them from the wild-type “smooth” 
strains, which express O-chain-bearing LPS (Erridge et al., 2002).   
 
Rough-mutant bacteria are serum-sensitive and are lysed by complement, 
whereas smooth strains, protected by their O-LPS polysaccharide chains, can 
survive in the host.  These smooth strains express a heterogeneous mixture of 
unsubstituted complete core (Ra) LPS and O-LPS with different chain lengths. 
Since only O-LPS and Ra-LPS occur in the host, these LPS are responsible for the 
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natural immunity detected when normal or clinical sera are studied with the various 
R-LPS and S-LPS as antigens in immunoassay.  When the incomplete-core R-LPS 
are used as immunogens, they can elicit novel antibody responses to the “break 
points” in the core oligosaccharide chains normally occupied by the missing outer 
sugars.  Such antibodies tend to be chemotype-specific, and may dominate 
following such vaccinations.  Immunoblotting on more complete LPS can often 
reveal their lack of reactivity, especially for monoclonals (Barclay, 2010).   
 
O-specific chains are present in smooth-type Gram-negative bacteria and 
pathogenic bacteria, and are in direct contact with the host during infection.  These 
chains help the bacteria to escape the lytic action of complement by a “shielding” 
process (Joiner, Schmetz, Leive & Frank, 1984).  A combination of 
monosaccharide diversity, the numerous possibilities of glycosidic linkage, the 
substitution and configuration of sugars, and the genetic capacities of the diverse 
bacteria all contribute to the uniqueness of the great majority of O-chain structures 
(Caroff & Karibian, 2003).  Even though broad diversity seems to be the rule in 
bacteria, serological cross-reactivity sometimes indicates similarities between O-
chain structures.  Brucella abortus and Yersinia enterocolitica O9 both have a 
homopolymeric O-chain structure composed of 4-amino-4,6-dideoxy-L-mannose 
residues (Caroff, Bundle & Perry, 1984; Caroff, Bundle, Perry, Cherwonogrodzky & 
Duncan, 1984).  Some O-chains consist of repetitive sugar units interlinked with 
other compounds such as hydroxybutyric acid or diamino-3-deoxy-nonulosonic 
acid (Vinogradov, MacLean, Crump et al., 2003).  Other O-chains are of the 
 18 
teichoic-acid type, with glycerol phosphate or with a phosphorylated aminopentonic 
acid (Dabrowski, Dabrowski, Katzenellenbogen et al., 1996).  Deoxy sugars are 
also frequent components in O-chain structures, but sugars that are more 
characteristic of the inner core region, like heptoses, are seldom present (Janson, 
1999). 
 
 
1.3 CYTOKINES 
During infection, the release of exogenous agents (microbial products) and 
endogenous mediators (cytokines and chemokines) contributes to the recruitment 
of circulating leukocytes to the inflamed tissue.  These microbial products trigger 
multiple cell types to release cytokines, which are potent inducers of chemokines.  
The primary cytokines act as endogenous activators of the immune response, 
whereas the inducible chemokines act as secondary mediators to attract 
leukocytes (Gouwy, Struyf, Proost & Van Damme, 2005).  Cytokines are protein 
molecules, and their name was derived from early observations that these 
molecules influences cell (“cyto”) movement (“kinesis”).  Cytokines play a pivotal 
role in regulating nearly every aspect of the immune response (Abbas & Lichtman, 
2003).  They are large molecules ( 15 kDa) and cannot cross the blood-brain 
barrier under normal circumstances (Maier & Watkins, 1998).  Cytokines are 
categorised into three functional groups based on their roles in:  innate immunity 
(interferon-(INF) alpha, Interleukin (IL)-1, IL-6, IL-10, IL-12, tumour necrosis factor 
 19 
alpha (TNF ) and the chemokines);  adaptive immunity (IL-2, IL-4, IL-5, INF-
gamma and transforming growth factor-beta); and haematopoiesis (colony-
stimulating factors, IL-3 and IL-7) (Abbas & Lichtman, 2003). 
 
Innate immunity (inflammatory response) is a relatively non-specific frontline 
defense that evolves over a period of hours to days against pathogens and in 
response to the disruption of tissue integrity (Miller, Pierce & Pariante, 2000).  The 
two principal types of immune cells, T helper (TH) cells and macrophages, are 
potent producers of cytokines.  Exposure to minute amounts of LPS provokes the 
innate immune responses in vitro and in vivo (Imrich, Ning, Koziel et al., 1999).  
The nature of the immune response may be dependent on the developmental 
stage of the subject (adult or infant) and on the sequence and mode of exposure to 
LPS and immune stimuli (Beutler & Poltorak, 2000).  The major pro-inflammatory 
cytokines TNF-  and IL-1ß are mainly produced by macrophages.  The TH1 subset 
(which also activates macrophages) mainly secretes IFN- , TNF-ß and IL-2.  The 
TH2 subset participates primarily in allergic and humoral responses and produces 
IL-4, IL-5 and IL-13.  TH1 and TH2 are defined by their functions and distinct 
cytokine production profiles (Elenkov & Chrousos, 2002; Romagnani, 1998).  IL-6 
is a pleiotropic cytokine that can simultaneously generate functionally distinct and 
sometimes contradictory signals through its receptor complex, IL-6R alpha and 
gp130 (Kamimura, Ishihara & Hirano, 2003).  [See Figure 1.5 for a ribbon 
representation of the IL-6 crystal structure.]  Elevated levels of pro-inflammatory 
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cytokines in the brain have been associated with the development of neurological 
disorders such as Alzheimer‟s disease (Krabbe, Pedersen & Bruunsgaard, 2004; 
Gupta & Pansari, 2003), vascular dementia (Krabbe, Reichenberg, Yirmira, Smed 
et al., 2005), Parkinson‟s disease (Gonzalez & Ezquerro, 2004), and human 
immunodeficiency virus (HIV)-associated dementia (Rafalowska, 1998). 
 
 
 
Figure 1.5 Ribbon representation of the IL-6 crystal structure.  “The four main 
helices are labeled A, B, C and D.  The extra helix in the final long loop is labeled 
E” (Somers, Stahl & Seehra, 1997). 
 
 
Adaptive immunity is a slower appearing specific immune response, and is 
mediated by B-lymphocytes and T-lymphocytes, which target specific recognition 
molecules on invading pathogens, or virally infected or neoplastically transformed 
cells (Miller et al., 2000).  Exposure to LPS may influence subsequent adaptive 
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immune responses to other immune stimuli (Abraham, Finn, Milton, Ryan et al., 
2005). 
 
 
1.4 RESPONSES TO ENDOTOXINS AND GRAM-NEGATIVE BACTERIA   
The signaling pathways alerting the host to the presence of LPS are similar in 
vertebrates, insects and plants (Hoffmann, Kafatos, Janeway & Ezekowitz, 1999).  
An important function of the innate immune system is to detect and recognise 
invaders.  The innate immune system initiates host defenses against invasive 
microbial pathogens using specific recognition mechanisms.  The pattern-
recognition systems of the innate immunity are highly specific, being capable of 
differentiating between “self” and pathogens.  Although LPS are the major 
virulence factor of Gram-negative bacteria, other components have been identified 
that are also able to induce inflammation [See table 1.1 for other components that 
can induce inflammation] (Heumann & Roger, 2002).  
 
Many extracellular and cellular elements in the complex host response systems to 
LPS have been elucidated (Elsbach, 2000).  Once bacterial components have 
been shed into the host, they activate host cells such as monocytes/macrophages, 
neutrophils and endothelial cells, to generate an inflammatory response.  This 
response can take place locally or systemically (Heumann & Roger, 2002).   
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Table 1.1 Components of Gram-negative bacteria known to induce 
inflammation (Heumann & Roger, 2002) 
 
Lipopolysaccharides 
Porins 
Lipopeptides 
Pili 
DNA (CpG motifs) 
Peptidoglycan 
Lipoproteins 
Lipid A-associated proteins 
Flagellin 
 
 
Upon entry of LPS in the host environment, plasma levels of LPS-binding protein 
(LBP) increase (Ulevitch & Tobias, 1999).  LBP is essential for the rapid induction 
of an inflammatory response by small amounts of LPS or Gram-negative bacteria 
(Jack, Fan, Bernheiden, Rune et al., 1997).  LPS aggregates are dissociated by 
LBP to form LPS/LBP complexes (Hailman, Lichenstein, Wurfel, Miller et al., 1994).  
The LPS/LBP complexes are transferred to a plasma membrane-bound LPS 
glycoprotein receptor, CD14 (mCD14), present prominently on mononuclear 
phagocytes and in smaller quantities on polymorphonuclear leukocytes (Jack et al., 
1997).  Granulocytes, monocytes and macrophages are not the only cells to 
possess the LPS-membrane receptors CD14 and Toll-like receptor 4 (TLR4); 
human corneal epithelial cells are also reported to express CD14 and TLR4 (Song, 
Abraham, Park, Zivony et al., 2001).  [See Figure 1.6 for an illustration of immune 
system activation].  Multiple mammalian receptors for LPS have been identified, 
i.e. 2-integrins CD11/CD18, the macrophage scavenger receptor for acetylated 
LDL, L-selectin and CD14 (Wright, Ramos, Tobias et al., 1990).   
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Figure 1.6 Activation of the human immune system by LPS (Nizet & Esko, 2009) 
 
 
1.5 DISPOSAL OF LIPOPOLYSACCHARIDES 
Removal of intact and presumably partially degraded LPS from the host is mainly 
through the liver and the biliary tract.  Various hepatic cellular elements are 
sequentially involved in the translocation of LPS and, after initial uptake by the 
Kupffer cells, LPS are present in the parenchymal cells (Feingold, Funk, Moser, 
Shigenaga et al., 1995).  Bacterial-associated LPS and cell-free LPS can enter 
extracellular and cellular disposal pathways.  Complex formations of LPS with a 
broad range of extracellular host proteins, including opsonins, antibodies and 
lipoproteins with, respectively, bacteria and shed LPS, lead to uptake by host cells¸ 
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primarily phagocytes that contain at least one LPS-degrading enzyme (acyloxyacyl 
hydrolase) (Elsbach, 2000). 
 
 
1.6 FOOD PRESERVATION 
“Then Moses said to them, „No one is to keep any of it until morning‟.  However, 
some of them paid no attention to Moses; they kept part of it until morning, but it 
was full of maggots and began to smell.”  Exodus 16:19-20 (NIV).  Since Biblical 
times there has been evidence of Man‟s struggle to preserve food for later use.  
Food preservation implies subjecting micro-organisms to hostile conditions, 
thereby causing death, inhibiting growth, or curbing their survival (Leistner, 1995a, 
1995b).  Most methods for extending the shelf-life of food rely on one or more 
physical factors, such as conventional thermal processing, which involves the 
effect of temperature on micro-organisms and food constituents followed by 
appropriate packaging and storage conditions (Lund, 2003).  [See table 1.2 for a 
summary of the environmental factors that affect changes in food constituents.]   
 
[See table 1.3 for the most important traditional and more recent methods for 
extending the shelf-life of food].  Within a food matrix, microbial growth kinetics 
depends on the effects and interactions of intrinsic and extrinsic conditions [See 
table 1.4 for factors affecting microbial growth] (McDonald & Sun, 1999).  During 
food preservation, one or more of these conditions are manipulated to a level 
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outside the range of growth of most foodborne micro-organisms (McDonald & Sun, 
1999). 
 
 
Table 1.2 Environmental factors affecting food constituents (Lund, 2003)  
 
PHYSICAL 
 
 
 
 
 
 
 
 
 
 
TISSUE 
 
Temperature 
Pressure 
Oxidation / reduction potential 
pH 
Enzymes 
Metals 
Leaching 
Light 
Processing / packaging chemicals 
Water activity 
 
Maturity 
Cultivar 
State of the tissue 
Composition 
 
 
 
Table 1.3 Processes for extending the shelf-life of foods (Lund, 2003) 
 
TRADITIONAL 
 
 
 
 
 
 
RECENT 
 
 
Thermal processing 
Freezing 
Cooling 
Drying 
Fermentation 
Packaging 
 
High hydrostatic pressure 
Ultrasonic treatment 
Pulsed electric field 
Oscillating magnetic fields 
High-intensity light 
Irradiation 
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Table 1.4 Intrinsic and extrinsic factors affecting microbial growth (McDonald & 
Sun, 1999) 
 
INTRINSIC FACTORS 
 
 
 
 
 
 
 
 
 
 
 
 
EXTRINSIC FACTORS 
 
 
 
pH, acidity, acidulant identity 
% buffering power 
Water activity and content 
Humectant identity 
Redox potential 
Presence of antimicrobials 
Identity and distribution of natural microbial flora 
Presence of physical structures 
Presence of biological structures 
Availability of nutrients 
Colloidal form 
Substrate surface-to-volume ratio 
 
Temperature 
Relative humidity 
Light intensity and wavelength 
Atmospheric gas composition and ratio 
Packaging characteristics and interactions 
Processing characteristics and interactions 
Storage, distribution and display considerations 
 
 
1.6.1 Hurdle Technology 
The development of alternative technologies for use as food preservation 
treatments has received considerable attention in response to consumer demands 
for more “fresh” and “natural” food products (Jeyamkondan, Jayas & Holley, 1999).  
In the case of most foods, the microbial safety and stability, as well as the sensory 
and nutritional quality, are based on the application of combined preservative 
factors (hurdles) (Leistner, 1995a).  Hurdles are used in industrialised and in 
developing countries for the gentle but effective preservation of foods (Leistner, 
2000).  Nonthermal processing techniques (such as HHP) are used in combination 
with various hurdles to eliminate the use of elevated temperatures during food 
processing, avoiding the adverse effect of heat on the nutritive value, flavour and 
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appearance of foods (Barbosa-Canovas, Gongora-Nieto, Pothakamury & 
Swanson, 1999).  There are, however, potential benefits to food safety when 
combining high temperature conditions with nonthermal processes, but the use of 
high heat negates the original goals of nonthermal processing (Ohlsson, 1994).   
 
 
1.6.2 The Hurdle Concept 
“Minimal processing” is a concept describing approaches to food safety and 
preservation that are directed at retaining the natural and as-fresh properties of 
foods (Manvell, 1997).  Nonthermal processes such as pulsed electric fields 
(PEFs), high hydrostatic pressure (HHP), ionising radiation and ultrasonication, are 
able to inactivate micro-organisms at ambient or sublethal temperatures.  Many of 
these processes do, however, require very high treatment intensities to achieve 
sufficient microbial inactivation in low-acid foods.  Combining two or more 
processes can enhance microbial inactivation and allow the use of lower individual 
treatment intensities.  Optimal microbial control can be achieved through the hurdle 
concept, with a synergistic effect resulting from different components of the 
microbial cell being targeted simultaneously, while their impact on the sensory and 
nutritive properties of the food is minimised (Leistner, 1992; Ross, Griffiths, Mittal & 
Deeth, 2003).   
 
Some of the hurdles applied to food preservation are temperature (low or high), 
water activity (aw), acidity (pH), redox potential (Eh), preservatives (e.g. sulphite, 
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nitrite, sorbate), and competitive micro-organisms (e.g. lactic acid bacteria).  More 
than 60 potential hurdles that improve the stability and/or quality of the products 
have been described (Leistner, 1999).  Some hurdles will influence the safety and 
the quality of foods, because they have antimicrobial properties and at the same 
time improve the flavour of the product (Leistner, 1994).  Therefore, the intelligent 
application of hurdle technology requires knowledge of the mechanisms of each 
hurdle applied (Leistner, 2000). 
 
 
1.6.3 High Hydrostatic Pressure 
Several authors have evaluated the effect of high hydrostatic pressure (HHP) 
processing on food chemistry and/or microbiology (Chawla & Chander, 2004; 
Erkmen & Doğan, 2004; Smiddy, O‟Gorman, Sleator, Kerry et al., 2005; Van 
Opstal, Banmuysen, Wuytack et al., 2005).  HHP processing involves the 
applications of static pressure of 50 to 1 000 mega Pascals (MPa) to solid or 
packaged liquid foods, with holding times varying from seconds to minutes 
(Mertens & Deplace, 1993; Williams, 1994).  Loss of cell viability begins at 
approximately 180 MPa, and the rate of inactivation increases exponentially as the 
pressure increases (Hauben, Wuytack, Soontjes & Michiels, 1996).  Substantial 
count reductions (>4log10 units) of most vegetative bacterial cells are obtained 
when a pressure treatment of 400-600 MPa at room temperature is applied 
(Hoover, 1993). 
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At low or moderate temperatures, HHP causes destruction of microbial vegetative 
cells and enzyme inactivation, leaving the vitamins intact, without changing the 
organoleptic characteristics of the product.  The efficacy of the treatment is 
dependent on the achieved pressure, the treatment temperature, the exposure 
time, the food matrix, and micro-organism resistance (Hugas, Garriga & Monfort, 
2002).  [See Figure 1.7 for a diagram of a typical HHP apparatus]. 
 
 
 
Figure 1.7 Schematic representation of a typical high hydrostatic pressure 
apparatus (Biomaterial Process Engineering Lab, 2010). 
 
 
Inactivation of the micro-organisms is probably the result of a combination of 
factors, so cell death is due to multiple or accumulated damage inside the cell 
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(Simpson & Gilmour, 1997).  The primary target of pressure damage is the cell 
membrane, mainly by altering its permeability as a consequence of phospholipid 
crystallisation.  The differences in membrane properties are determining factors in 
the pressure or stress sensitivity of micro-organisms (Vogel, Molina-Guiterrez, 
Ulmer et al., 2001).  Membrane permeability is affected by compression of the 
membrane‟s bilayer and a reduction in the cross-sectional area per phospholipid 
molecule (Datta & Deeth, 1999).  HHP damages the membranes, affecting the 
transport phenomena involved in nutrient uptake and disposal of cell waste.  
Intracellular fluid compounds have been found in the cell-suspending fluid after 
pressure treatment, demonstrating that leaks occur while cells are held under 
pressure (Shimada, Andou, Naito, Yamada et al., 1993).  The high pressure affects 
noncovalent bonds, leaving covalent bonds intact (Knorr, 1993) and, as a result, 
induces alterations in the structure of secondary- and tertiary-bonded molecules 
(Datta & Deeth, 1999).  Other cellular functions that are sensitive to pressure are 
cell morphology, protein denaturation, inhibition of enzyme activity, and 
destabilisation of DNA replicative complex (Vogel et al., 2001).   
 
Spores and Gram-positive bacteria are on average more resistant to HHP than 
Gram-negative bacteria.  The higher resistance of Gram-positive bacteria to HHP 
may be linked to the rigidity of the teichoic acids in the peptidoglycan layer of the 
Gram-positive cell wall (Arroyo, Sanz & Prestamo, 1999).  The higher resistance of 
bacterial spores to physical stress, solvation and ionisation is linked to the 
protective effect of the membranes and coat surrounding the core, the presence of 
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dipicolinic acid, and the low water activity in the spore core (Timson & Short, 1965).  
Cocci are also more resistant than bacilli, which appears to be because the 
reduced cell surface (cocci) area in contact with the environment may limit cell 
leakage at a given treatment intensity, thus minimising the effect of the treatment 
(Arroyo et al., 1999).  Cells in the exponential growth phase are more sensitive to 
pressure than cells in the stationary phase (Archer, 1996).   
 
Variation in HHP resistance in different strains must be taken into consideration 
when setting up processing regimes (Hugas et al., 2002).  Inactivation of micro-
organisms is improved with the application of temperatures that are higher or lower 
than the optimal growth temperature of the organism (Smelt, 1998).  [See table 1.5 
for a summary of the opportunities and drawbacks of HHP]. 
 
 
Table 1.5 Opportunities and drawbacks of HHP (Devlieghere, Vermeiren & 
Debevere, 2004) 
 
OPPORTUNITIES 
 
 
 
 
 
 
DRAWBACKS 
 
 
High retention of nutrients and vitamins 
High fresh-like organoleptical quality 
Applicable for acid foods (as spores will not germinate in 
acidic foods) 
Spores can be inactivated when combined with heat or 
lactoperoxidase system or lysozyme 
 
Discontinuous for solid, viscous and particulate foods 
Semi-continuous for liquid foods 
High investment costs 
Spores are not sensitive 
Bacteria have been shown to become resistant 
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1.7 RATIONALE 
Foodborne diseases are a worldwide public concern, in both developed and 
developing countries.  In order to manage food safety effectively, it is essential to 
acquire knowledge of the occurrence and control of these foodborne pathogens.  
The changing lifestyles of the modern population have resulted in an increased 
demand for ready-to-eat food.  This, however, has also led to the increased risk of 
food poisoning.  It is estimated that in the United States of America, more than 75 
million cases of food poisoning occur annually, resulting in approximately 5 000 
deaths per year (Acheson, Calderwood, Moynihan & Baron, 2009). 
 
Various effective preservation methodologies are used to control these pathogens 
in food.  However, consumer demand for safe food with a fresh taste has resulted 
in the development of alternative technologies to the conventional heat 
preservation methods.  HHP is a method of food processing that involves the 
application of pressure to achieve microbial inactivation.  This methodology can be 
used in conjunction with other preservation techniques, such as heat or cold and 
antimicrobials, to enhance the efficacy of the treatment.  HHP does not change the 
organoleptic characteristics of food and is especially beneficial for heat-sensitive 
products.  Numerous studies have evaluated the efficacy of this preservation 
methodology on the viability of organisms.  However, as far as is known, none of 
these studies have focused on the toxicity of post-HHP organisms.  By means of 
this study, the influence of high hydrostatic pressure on organism viability and 
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liberation and the toxicity of LPS produced by foodborne pathogens will be 
assessed.   
 
The specific aims of this study were: 
 
1. To quantify bacterial cell viability after the application of HHP (E. coli, 
Staphylococcus aureus and Listeria monocytogenes). 
2. To evaluate the influence of HHP on the quantity of LPS of E. coli O111 
liberated into the extrinsic environment. 
3. To determine the influence/effect of HHP treatments on the LPS toxicity of 
E. coli O111. 
4. To evaluate a porcine cytokine (IL-6) expression system as a possible 
alternative to the customarily applied Limulus Amoebocyte Lysate (LAL) 
endotoxin quantification kit (E. coli O111). 
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2. GROWTH RESPONSE OF ESCHERICHIA COLI O111 
SUBJECTED TO SUBLETHAL HIGH HYDROSTATIC PRESSURE 
 
2.1 HIGH HYDROSTATIC PRESSURE 
Modern food preservation techniques are progressively relying on processes that 
have negligible effects on food systems but will result in microbiological safety by 
an intelligent synergistic combination of mild stress factors.  The use of high 
hydrostatic pressure (HHP) for food processing is finding increased application 
within the food industry although the technology has been available for over a 
century (Hite, 1899).  Conversely, high-pressure bioscience has reached maturity 
with a sphere of application that is unlimited.  Due to these technological 
developments, the use of HHP is no longer restricted only to food processing; it is 
gradually being applied in the medical and pharmaceutical sciences.  For example, 
high-pressure inactivation is being successfully used to sterilise fragile 
biopharmaceuticals and medical substances. Moreover, the enhanced 
immunogenicity of pressure-inactivated micro-organisms could be applied for the 
production of new vaccines and animal tissue, while blood and cells and organs for 
transplants could be stored at subzero temperatures without freezing (Masson, 
Tonello & Balny, 2001).   
 
Advances in the food industry have shown that the application of HHP, which does 
not necessarily make use of heat, enhances the appearance, texture, flavour and 
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nutritional qualities of food, thus yielding a product with better quality than those 
processed by conventional methods (Farkas & Hoover, 2000; San Martin, 
Barbosa-Cánovas & Swanson, 2002).  High pressure, in contrast to heat, does not 
disrupt covalent bonds of the primary protein structures and renders them relatively 
unchanged and for the most part suitable for food with ingredients that are 
undesirably altered by heat (Cheftel & Culioli, 1997; Murchie, Cruz-Romero, Kerry, 
Linton, Patterson, Smiddy et al., 2005).  The most commendable characteristic of 
HHP processing is that pressure acts instantaneously and uniformly through the 
treated matrix and consequently independently of matrix composition, size or 
shape and equipment size (Butz & Tauscher, 2002).  Because transmission of 
pressure to the core is not mass or time dependent, the process is minimised 
(Aymarich, Picouet & Monfort, 2008).  HHP has the ability to inactivate micro-
organisms, as well as enzymes, thereby extending the shelf-life of the treated 
matrix (San Martin et al., 2002).  Several extrinsic/intrinsic factors do, however, 
govern successful microbial inactivation:  the type and strain of organism, the 
growth phase, temperature, time, pressure, pH and water activity, and the 
composition of the surrounding medium (Hugas, Garriga & Monfort, 2002). 
 
 
2.2 INACTIVATION OF PATHOGENIC MICRO-ORGANISMS 
Consumer demand for high-quality food with a “fresh” taste and a stable shelf-life 
has led to the concept of minimal processing and has prompted research into non-
thermal food preservation techniques as alternative to the traditional techniques.  
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HHP is increasingly being employed for the commercial processing of oysters 
(Crassostrea), and high-pressure technology is proving particularly useful to the 
industry.  Oysters, which are bivalve shellfish, are typically consumed raw or 
slightly cooked and can pose a severe threat to public health if contaminated with 
food-borne pathogenic micro-organisms (Altekruse, Yang, Timbo & Angulo, 1999; 
Kural & Chen, 2008).  Oysters are filter feeders, passing copious volumes of water 
through the gills for nutritional and gaseous requirements, and thereby bio-
accumulating micro-organisms from the surrounding waters (Cliver, 1995; Murchie 
et al., 2005).  The presence of pathogenic bacteria, noroviruses and enteric viruses 
such as hepatitis A are not only a threat to the safety of shellfish worldwide 
(Beuret, Baumgartner & Schluep, 2003; Chironna, Germinario, De Medici, Fiore, Di 
Paquale, Quarto et al., 2002; Kingsley, Meade & Richards, 2002) but could also 
have an impact on international trade (Ristori, Iaria, Gelli & Rivera, 2007).  In 
recent years members of the Vibrionaceae family, in particular Vibrio vulnificus and 
Vibrio parahaemolyticus, have received attention from researchers due to their 
prevalence in outbreaks of food-borne diseases related to the consumption of 
contaminated shellfish (Cook, 2003; Kural & Chen, 2008; Kural, Shearer, Kingsley 
& Chen, 2008; Mahmoud, 2009; Prapaiwong, Wallace & Arias, 2009).  [Table 2.1 
highlights some of the effects of HHP on various oyster pathogens].   
 
In addition to extending the shelf-life of oysters, HHP treatment has the additional 
advantage of shucking (opening) shellfish, making this food-processing technology  
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Table 2.1.  Inactivation profiles of some of the pathogenic bacteria and viruses responsible for food-borne diseases 
resulting from the consumption of contaminated shellfish 
 
   
 
Treatment parameters  
 
Reference 
 
Organism 
 
Suspending medium 
 
Pressure 
(MPa) 
 
Time 
(minutes) 
 
Temp 
(ºC) 
 
Log 
reduction 
 
Li et al. (2009)  
 
Murine norovirus-1 
 
Oysters 
 
400 
 
5 
 
0 
 
Undetectable 
Kural et al. (2008) 
 
Kural and Chen (2008) 
V. parahaemolyticus 
 
V. vulnificus 
 
Oysters 
Oysters 
Oysters 
Oysters 
Oysters 
≥350 
≥300 
150 
150 
150 
2 
2 
4 
4 
4 
1-35 
40 
-2 
1ºC 
20 
5 
5 
4.7 
2.8 
0.5 
Grove, Forsyth, Wan, 
Coventry, Cole, Stewart et al. 
(2008) 
Polio virus Cell culture medium 600 5 ambient no reduction 
Calci, Meade, Tezloff and 
Kingsley (2005)  
Hepatitis A Oysters 
Oysters 
Oysters 
350 
375 
400 
1 
1 
1 
8.7–10.3 
8.7–10.3 
8.7–10.3 
>1 
>2 
>3 
Smiddy, O‟Gorman, Sleator, 
Kerry, Patterson, Kelly et al. 
(2005) 
E. coli PBS 
Oysters 
PBS 
200 
400 
400 
5 
5 
5 
20 
20 
20 
no reduction 
1 
3 
Cook (2003) V. vulnificus 
V. parahaemolyticus 
(O3:K6) 
Oysters 
Oysters 
 
250 
300 
2 
3 
- 
- 
>5 
>5 
Kingsley, Hoover, Papafragkou 
and Richards (2002) 
Feline calicivirus Cell culture medium 275 5 ambient >6 
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particularly advantageous to the shellfish industry and consumers (Murchie et al., 
2005).  Li, Tang, Wang, Wang, Zhao and Xue (2009) showed that HHP treatment 
applied at 200-400 MPa did not influence the visual appearance of the oysters and 
effectively facilitated shucking.  He, Adams, Farkas and Morrissey (2002) also 
reported that HHP treatment at 242 MPa for two minutes caused detachment of the 
adductor muscle in 88% of oysters, while treatment at 310 MPa with instantaneous 
pressure release resulted in 100% shucking (He et al., 2002).   
 
 
2.3 ESCHERICHIA COLI 
E. coli is a Gram-negative, facultative anaerobic bacillus that forms part of the 
normal biota in the human intestinal tract. Some serotypes are nonetheless 
infamous for causing food poisoning.  The inactivation of E. coli by HHP has 
received much attention, not only as far as the pressure treatment conditions (time, 
pressure, temperature) are concerned, but also with regard to the possible effect of 
HHP on the physiological status of the cell.  A study conducted by Casedei, 
Mañas, Niven, Needs and Mackey (2002) proved that exponential- and stationary-
phase cells showed surprising differences in response to pressure resistance.  In 
exponential-phase cells, pressure resistance decreased as growth temperature 
increased, whereas in stationary-phase cells, pressure resistance increased to a 
maximum of 30 at 37 ºC and then dropped. The results showed that the difference 
in pressure resistance between exponential- and stationary-phase cells varies 
depending on growth temperature.  At the optimum growth temperature of 37 ºC 
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for E. coli the differences were considerable, while the differences were less 
pronounced when cells were grown at 10 ºC.  A possible explanation is that the 
protective stationary-phase responses were not induced to the same extent in cells 
grown at 10 ºC.  The study confirmed that the membrane is a critical target in 
pressure inactivation, but also suggests that there are fundamental differences in 
the role of the cell membrane in determining the pressure resistance of 
exponential- and stationary-phase cells (Casadei et al., 2002).  Linton, 
McClements and Patterson (2001) showed that the pressure resistance of two 
E. coli strains (NCTC 11601 and NCTC 9706) also varied depending on the length 
of time the cells had been in the stationary phase.  When cells were exposed to 
HHP in the early stationary phase, and after an extended time in the stationary 
phase, the number of cells that survived pressure treatment of 600 MPa for 10 
minutes increased slightly, but not significantly, for up to five days.  Cell viability 
then decreased considerably with time until, after seven days in the stationary 
phase, no surviving cells were detected after HHP treatment.  This tendency was 
also comparable to viable counts in the cultures used for high hydrostatic pressure 
treatments, which started to decrease four to five days after the onset of the 
stationary phase.  The increase in pressure sensitivity correlated with the onset of 
the death phase.  This must be taken into consideration when foods are processed 
by high hydrostatic pressure, as micro-organisms may be present in foods in a 
wide range of physiological states and as a result their sensitivity to high pressure 
can differ extensively (Linton et al., 2001). 
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Enterohaemorrhagic E. coli (EHEC) is one of the leading microbiological 
challenges encountered in the food industry and poses a global threat. The 
presence thereof in fresh/organic products intended to be eaten raw can cause 
serious illness, leading to fatality in some cases and/or lifelong sequelae (kidney 
failure) in other cases.  The minimum infective dose of these organisms compared 
to other food-borne pathogens is reported to be <100 colony forming units (CFUs) 
(Bell, 2002).  Even though E. coli O157:H7 has received significant attention as a 
food-borne pathogen, other groups of verocytotoxin (VT) producing E. coli (VTEC) 
serogroups – also known as Shiga toxin-producing E. coli (STEC) – have emerged 
and have increasingly been implicated in food-borne illnesses, e.g. serotypes 
O26;H11, O103;H2, O111;H2 and O145;H28 (Bell, 2002). Various researchers 
have reported the presence of the virulence genes verocytotoxin 1 (vtx1) and 
verocytotoxin 2 (vtx2), which are associated with strains (O111) causing 
haemorrhagic colitis and haemolytic-uremic syndrome (Jothikumar & Griffiths, 
2002; Nielsen & Andersen, 2003; Pearce, Evans, McKendrick, Smith, Knight, 
Mellor et al., 2006).  Within the STEC family certain strains appear to be of greater 
virulence for humans. E. coli O111 is responsible for enterohaemorrhagic and 
enteropathogenic diseases in humans (Nataro & Kaper, 1998) and is of special 
concern in developing countries where it is a classic cause of diarrhoea in children.  
Infections from EHEC may result from contact with infected animals (especially 
cattle) and their faeces, beef products, and fruits and vegetables such as 
cantaloupe, lettuce, apple cider and potatoes (Ackers, Mahon, Leahy, Goode, 
Damrow, Hayes et al., 1998; Armstrong, Hollingswirth & Morris, 1996; Besser, Lett, 
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Weber, Doyle, Barrett, Wells et al., 1993; Feng, 1995; Morgan, Newman, Palmer, 
Allen, Shepherd, Rampling et al., 1988).  STEC was also detected in retail 
shellfish, turkey, lamb, fish and pork (Samadpour, Ongerth, Liston, Tran, Nguyen, 
Whittam et al., 1994).  The infectious dose of STEC is low, as was observed with 
an STEC O111;H- outbreak in Australia where the implicated fermented sausages 
contained fewer than one E. coli O111 organism per 10 g.  The diseases caused 
by E. coli have rendered EHEC a major threat to public health (Paton, Ratcliff, 
Doyle, Seymour Murray, Davos et al., 1996).  STEC is able to survive in slurries, 
farmyard manure and sludge, on pastureland and in aquatic environments.  As the 
coast acts as a receptacle of agricultural and urban waste water effluents, STEC 
could therefore be present in coastal waters (Alam, Hasan, Ahsan, Pazhani, 
Tamura, Ramamurthy et al., 2006; Garcia-Aljaro, Muniesa, Blanco, Blanco, Blanco, 
Jofre et al., 2005; Gourmelon, Montet, Lozach, Le Mennec, Pommepuy, Beutin et 
al., 2006; Pearce et al., 2006).  However, little is known about the prevalence of 
STEC non-O157 serotypes as contaminants in shellfish and the role they play in 
food-borne disease.   
 
Considering that oysters are pressured in the region of 200 MPa, which is sufficient 
to shuck the oysters and inactivate various Vibrio species and some viruses, E. coli 
O111 was selected for high-pressure studies, as it is an emerging pathogenic 
contaminant in shellfish.  This study aimed to investigate the response of E. coli 
O111 to 200 MPa, the influence of bacterial concentration on the inactivation of 
vegetative E. coli O111 cell suspensions, the use of different enumeration methods 
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to assess cell damage, and the evaluation of growth phases (surviving cells) in 
order to shed light on subsequent cellular repair after sublethal injury.  
 
 
2.4 MATERIALS AND METHODS 
2.4.1 Propagation Of Organisms 
Stock cultures of E. coli O111 were kept in vials containing treated beads in a cryo-
protective fluid (Microbank, Davies Diagnostics, SA) at -80 °C until needed.  
Bacterial growth was activated by placing a bead in 250 ml buffered peptone water 
(Biolab, Merck, SA), and incubated for 16 hours at 37 °C with agitation (75 
revolutions per minute).  The cells (exponential phase) where then subjected to 
HHP. 
 
 
2.4.2 High-Pressure Equipment 
Pressurisation experiments were performed in a prototype high-pressure 
instrument exclusively built for purposes of this study.  The initial temperatures of 
the vessel jacket were adjusted to 8 °C and 50 °C respectively by circulating a 
water solution until the water temperature stabilised.  This instrument had no 
heating/cooling jacket to control the temperature of the vessel; therefore the 
temperature was measured before the vessel was closed and again after high-
pressure treatment.  The average temperature of the pressurisation fluid after 
treatment was 18.5 ±1.5 ºC for the 8 ºC pressures and 26.5 ±1.5 ºC for the 50 ºC 
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pressures.  The pressure transmission fluid used was distilled water.  The diameter 
of the chamber was 40 millimetre (mm) and the depth 80 mm. 
 
 
2.4.3 High-Pressure Treatment 
Aliquots of 10 millilitre (ml) of the broth were transferred to sterile polyethylene 
bags (6 x 8 cm).  The bags were double heat-sealed, taking care to expel most of 
the air from the bag.  The samples (control and test) were kept on ice prior to 
pressurisation, which did not exceed one hour.  The sealed bags were conditioned 
for five minutes prior to pressurisation in a water bath set to 8 °C for pressurisation 
at the same temperature and 50 °C for pressurisation at 50 °C.  Test samples were 
pressurised at 200±5 MPa for 15 minutes at the starting temperature of the 
pressurisation fluid of 8 °C and 50 °C respectively.  Come-up times varied from 36 
to 42 seconds and decompression time was instantaneous.  After pressurisation 
the sealed bags were removed from the chamber and kept on crushed ice prior to 
viability quantification (within one hour).  Every test sample subjected to 
pressurisation (test) had a parallel control sample (held at 8 ºC and 50 ºC 
respectively) that was not subjected to pressurisation.  Identically prepared 
samples treated for 15 minutes in an autoclave at 121 °C served as a dead cell 
control.   
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2.4.4 Enumeration Of Organisms 
After high hydrostatic pressure treatment the samples were enumerated and 
subsequently subcultured by inoculating 100 micro litre (µl) of the sample in 150 ml 
buffered peptone water and incubating at 37 °C with agitation.  Subsequently, 
enumeration of organisms and optical density determinations were performed at 6, 
18, 24, 30, 42 and 48 hours. 
 
 
2.4.4.1 Cell Viability 
The number of viable culturable cells was quantified by the plate count method.  
One millilitre of each cell suspension was serially diluted in sterile physiological 
saline (9 ml) and 100 µl surface plated in duplicate on brain heart infusion agar.  
After 16 hours of aerobic incubation at 37 °C the colonies were enumerated using 
a semi-automated IUL colony counter (Optolabor, SA).  Plates with colony counts 
lower than 50 and higher than 300 were deemed unsatisfactory.  Results were 
calculated as colony-forming units per millilitre (CFU ml-1). 
 
 
2.4.4.2 Intact Cells 
Intact cells in the suspensions were counted in a FAST-READ 102 counting 
chamber (Davies Diagnostics, SA) after mixing equal parts of the sample with 
Trypan blue stain.  The number of cells within four squares (dimension 1 x 1 mm) 
was counted and the mean calculated and expressed as cells per µl. 
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2.4.4.3 Optical Density 
Optical density for the various samples was determined at 620 nm on a Heλios ε 
spectrophotometer (Merck, SA). 
 
 
2.4.5 Statistical Analysis 
The experiments were performed in duplicate, and the data presented is the mean 
value ± standard deviation.  The F-test was employed to qualify significance 
between different treatments and incubation times, and differences between the 
means were considered significant when P≤0.05.   
 
 
2.5 RESULTS 
Two sets of E. coli suspensions were subjected to pressure at 200 MPa for 15 
minutes with starting temperatures of the samples at 8 ºC and 50 ºC.  The first set 
of experimentsa represented a lower bacterial load (OD < 0.2), while experimentsb 
represented a higher bacterial load (OD >0.7).  Percentage difference (PD) 
between the test organism (pressurised) and the corresponding control (ctrl) 
organism (not pressurised) was calculated at each time interval for colony-forming 
units, intact cell count and optical density.  With the exception of 8a no significant 
difference (P≥0.05) in cell viability was observed when compared to the controls.  
Therefore, the difference at individual time intervals was considered and presented 
as percentage difference (PD), calculated as follows: 
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T = Test value 
t = Time 
C = Control value 
 
A PD of <25% was considered to be within experimental variability.  A positive 
percentage value indicates that growth of the test organism (pressurised) was 
weaker than that of the control, while a negative value indicates the opposite (this 
is applicable to all the enumeration parameters).  Table 2.2 shows an outline of the 
percentage differences.  
 
 
2.5.1 Cell Viability 
With the exception of 8b and 50b the test organisms and controls generally behaved 
the same.  However, a notable PD (+34) was observed at zero hours for 50b, and 
at six hours a high PD (>77) was observed for all the treatment parameters.  
Furthermore, an elevated PD was noted for both 8a and 50b during the time interval 
18 – 42 hours.  Within this timeframe 8a presented a positive PD indicating that the 
control cells proliferated at a slightly increased rate compared to the test cells. In 
contrast, the PD at 50a generally showed the opposite.  The PD observed at 48 
hours was insignificant.   
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Table 2.2 Percentage differences in the growth of E. coli O111 observed for each of the treatment  
procedures (200MPa 15min-1) 
                
 
  
Difference (%) 
Comparison 
with control  
(P≤0.05) 
  
Treatment 
temp (ºC) 
0 H 6 H 18 H 24 H 30 H 42 H 48 H 
 
CFU  8
a
 2 94 56 72 60 71 4 
 
0.040* 
 8
b
 -17 90 8 -2 -2 5 13 0.324 
 50
a
 12 96 -66 -24 -413 40 -19 0.128 
 50
b
 34 77 9 -22 1 11 8 0.367 
          
ICC  8
a
 -13 40 -34 3 38 8 -25 
 
0.417 
 8
b
 8 69 5 7 22 20 6 0.486 
 50
a
 90 25 -41 -103 24 -3 25 0.457 
 50
b
 8 46 5 -4 8 14 6 0.486 
          
OD  8
a
 5 67 18 12 4 0.2 -1 0.414 
 8
b
 -2 72 7 6 5 6 5 0.410 
 50
a
 11 97 16 29 21 2 2 0.489 
 50
b
 2 48 2 -0.5 -3 -3 -2 0.394 
CFU – colony-forming units; ICC – intact cell count; OD – optical density; H – time (hours) 
(
a
) – low bacterial load; (
b
) – high bacterial load 
(*) – significant difference 
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2.5.2 Intact Cells 
No significant difference (P≥0.05) between the test and control treatment 
parameters was observed.  However, a notable PD (+90) was observed for 50a at 
zero hours, which is the opposite of that observed with cell viability.  A notable PD 
(>25) was observed after six hours of incubation for all the treatment parameters 
(similar to cell viability).  At 18 hours a PD of -34 and - 41 was observed 
respectively for 8a and 50a, while the same tendency was also observed with cell 
viability.  In general no elevated PD was observed with 8b and 50b, although a high 
PD was observed from 18 – 30 hours.  The PD observed at 42 and 48 hours was 
insignificant.  
 
 
2.5.3 Optical Density 
As was observed with the intact cell count, no significant differences were 
observed between the test and control treatment parameters.  In this instance the 
only significantly high PD (>48) was observed at six hours for all treatment 
parameters, with a slightly elevated PD at 24 hours for 50a.  
 
 
2.6 DISCUSSION 
HHP involves the application of static pressure of 50 to 1 000 mega Pascal (MPa) 
to solid or liquid packed foods/matrixes, with holding times varying from a few 
seconds to several minutes (Mertens & Deplace, 1993; Williams, 1994).  Loss of 
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bacterial cell viability begins at approximately 180 MPa, and the rate of inactivation 
increases exponentially as the pressure increases (Hauben, Wuytack, Soontjes & 
Michiels, 1996).  Considerable count reductions (>4log10 units) of most vegetative 
bacterial cells can be achieved when pressure treatments of 400-600 MPa are 
applied at room temperature (Hoover, 1993).   
 
For this study, E. coli O111 was subjected to sublethal HHP treatment, and the 
recovery of surviving pressurised cells was facilitated by incubation in buffered 
peptone water.  Pressurising organisms results in inactivation of or injury to the 
organisms, but this is nonetheless dependent on the species and strain of the 
bacteria, the pressure levels and subsequent storage conditions.  Initial 
assessment showed that pressure-induced cell damage (PD – CFU/ICC) was not 
as pronounced as was observed for 8a (CFU) and 50a (ICC).  Pressurised cells in 
the late exponential phase (after 14 – 16 hours of incubation) initiated growth with 
a short (six-hour) lag phase followed by exponential growth up to 48 hours and 
subsequent stationary-phase growth.  A significant PD was observed (end of lag 
phase) at six hours with all assessments, indicating sublethal injury of the bacterial 
cells and denoting an increased amount of energy channelled towards metabolic 
adaptation rather than growth.  In general, E. coli O111 (exponential cells) seemed 
resistant to HHP, especially at shucking pressures.  These findings contradict 
some of the views expressed in the literature, since subsequent growth (after the 
lag phase) of the pressurised cells differed only slightly from that of the control 
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cells.  According to Archer (1996) cells subjected to higher pressures (600MPa for 
10 minutes) only recovered after exponential growth. 
 
The conditioning temperatures of 8 ºC and 50 ºC respectively for five minutes and 
subsequent pressurisation at these temperatures did not seem to have a significant 
influence on PD.  However, in this study the cells were incubated at 37 ºC prior to 
conditioning, and different results might be observed if the cells are incubated at a 
suboptimum temperature, inducing heat/cold shock (Aertsen, Vanoirbeek, De 
Siegeleer, Sermon, Hauben, Farewell et al., 2004; Serrazanetti, Guerzoni, Corsetti 
& Vogel, 2009).  Another contributing factor to the limited differences between the 
control/test cells could be that the treatment temperatures of 8 ºC and 50 ºC 
respectively were not maintained for the duration (15 minutes) of the 
pressurisation, and this had a negligible effect on bacterial inactivation.  However, 
for 8a (CFU), metabolic adaptation (prolonged lag phase) was more pronounced 
than for any other treatment conditions.  This would indicate that a lower bacterial 
concentration and lower treatment temperature are more likely to induce cellular 
damage. This finding supports the results of Furukawa, Noma, Shimoda and 
Hayakawa (2002) who reported that bacterial concentration and inactivation rate 
are inversely proportionate to each other.  Though HHP-induced damage to the 
cell membranes could result in cell death, substantial evidence exists that E. coli 
cells could survive or repair membrane damage in order to continue proliferation 
(Chilton, Isaacs, Mañas & Mackey, 2001).  The variances observed in the PD of 
 72 
CFUs and ICC could be attributed to cells aggregating and/or the presence of 
viable but non-culturable organisms, thus being reliant on the physiological status 
of the cell and cell age.  From the results it would seem that cellular repair occurred 
within 30 to 42 hours (CFU and ICC).  In view of the relatively small PD observed 
with optical density determinations, it would seem that differences in bacterial 
concentrations (a vs. b) and the different treatment temperatures (8 ºC and 50 ºC) 
had a negligible effect on E. coli O111.  The significant PD observed after six hours 
in all the treatment instances was most likely the result of the restoration of growth 
capabilities.  Thereafter cellular repair as determined by OD seemed to have been 
completed after 18 hours.  It should also be noted that sublethal HHP results in a 
more pronounced metabolic adaptation or structural correction rather than a 
morphological change as is seen for E. coli O111. 
 
The intelligent application of HHP as a preservation process requires an 
understanding of microbial physiology and cell behaviour before, during and after 
treatment.  From the results it could be concluded that sublethally injured micro-
organisms could still present a potential threat in food safety given that they are 
able to repair themselves under suitable conditions.  Care should thus be taken 
when culturing post-HHP micro-organisms on selective growth substrate, as the 
additional stress combined with the time to adapt metabolically might result in a 
false negative result.  Therefore it is advisable to consider enrichment for at least 
18 hours prior to selective cultivation.  The concentration of microbes would also 
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dictate the preservation approach when applying HHP.  Preservation 
methodologies ought to rely on a combination of factors such as depuration prior to 
HHP for more successful decontamination of fresh oysters and a reduction in 
microbial counts.  It should be noted that high-protein environments such as 
oysters have a baro-protective effect (Narisawa, Furukawa, Kawarai, Ohishi, 
Kanda, Kimijima, et al., 2008) making it difficult to extrapolate the data obtained in 
this study directly to other matrixes.  However, the results do show that an incorrect 
approach to the time of analysis for quality control purposes could yield false 
negative results.  Moreover, when studying the post-HHP growth of E. coli O111, 
growth should be assessed at short intervals from the onset of growth to ensure 
that cell repair is observed.  Furthermore, the application of hurdle technology 
(combined treatments) should be approached with care, as an increase in 
temperature combined with HHP could result in cells (present in low numbers) 
improving in condition (compared to control) after metabolic adaptation and 
structural repair.  Finally, further studies should be conducted to assess the 
virulence of post-HHP E. coli O111, as metabolic adaptation and cell repair might 
also impact on lipopolysaccharides (LPS), toxin structure (Venter, Abraham, Lues 
& Ivanov, 2006), the ability to form biofilm, as well as the accuracy of serological 
assessment. 
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CHAPTER 3 
 85 
3. GROWTH RESPONSE OF LISTERIA MONOCYTOGENES (UAFSB 
CULTURE COLLECTION) AND STAPHYLOCOCCUS AUREUS (ATCC 
25923) SUBJECTED TO SUBLETHAL HIGH HYDROSTATIC PRESSURE 
 
3.1 FOOD-BORNE PATHOGENS AND PRESERVATION 
Millions of episodes of illness annually can be traced back to contaminated food 
and water (Hayes, Elliot, Krales & Downer, 2003).  The impact of food-borne 
pathogens on health is still an important issue, although the spectrum of food-
borne infections has changed over time, as well-established pathogens have been 
controlled or eliminated and new ones have emerged.  A vast number of 
pathogenic micro-organisms can contaminate food and water supplies and cause 
illness if they or their toxins are consumed.  Included in this vast spectrum of food-
borne pathogens are anaerobes and aerobes, parasites and viruses, enteric 
bacteria, marine dinoflagellates, bacteria that produce biotoxins in shellfish and 
fish, and the self-inducing prions of the transmissible encephalopathies.  
Regardless of the route of transmission, such pathogens cause an array of human 
illnesses, mostly gastrointestinal.  The term „food-borne disease‟ thus refers to 
numerous different pathogens and diseases (Tauxe, 2002).  The pathogenesis of 
the food-borne bacteria that cause food poisoning is dependent on their capacity to 
produce toxins in the food matrix or to produce toxins after ingestion (Le Loir, 
Baron & Gautier, 2003). 
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Evaluation of any food preservation technology depends on a reliable assessment 
of its efficacy against pathogenic and spoilage food-borne micro-organisms.  
Research on alternative preservation technologies was originally focused on 
process design, product characteristics, and kinetics of microbial inactivation.  
Recently, however, there has been greater emphasis on understanding microbial 
physiology and behaviour of microbial cells before, during and after treatment 
(Lado & Yousef, 2002).  Within a food matrix, microbial growth kinetics depends on 
the effects and interactions of intrinsic and extrinsic conditions.  For that reason it is 
typical for one or more of these conditions to be manipulated to a level outside the 
range of growth of most food-borne and spoilage micro-organisms (McDonald & 
Sun, 1999).  What is required, therefore, is a multidisciplinary research approach 
that combines microbiological, physical, biochemical and engineering principles to 
demonstrate the efficacy of these alternative food preservation methods 
(Balasubramaniam, Ting, Stewart & Robbins, 2004). 
 
 
3.2 HIGH HYDROSTATIC PRESSURE 
Consumer demand for fresher foods with an extended shelf-life and which are 
microbiologically safe and additive free has led to the development of different food 
preservation technologies as alternatives or enhancements to the traditional 
preservation techniques (Rastogi, Raghavarao, Balasubramaniam et al., 2007).  
Raso and Barbosa-Cánovas (2003) characterised the attributes of an ideal 
preservation method as: it must be acceptable to regulatory bodies and 
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consumers; the organoleptic and nutritional qualities of the food must remain intact; 
it must not leave any residues; it must be convenient and cheap; and it must 
inactivate micro-organisms.   
 
For several years now, the practice has been to use high-pressure treatment in the 
production of plastics, ceramics, carbon graphite and composite material.  Such 
technological developments have enhanced the feasibility of the use of high 
hydrostatic pressure (HHP) in food preservation (Smelt, 1998), and nowadays HHP 
is enjoying increased application in the medical and pharmaceutical sciences 
(Masson, Tonello & Balny, 2001).  High-pressure technology has been in use since 
1990 in the food industry as a food-preservation technique (Cléry-Barraud, 
Gaubert, Masson & Vidal, 2004).  This technique has attracted considerable 
research attention as a means to inactivate spoilage and pathogenic micro-
organisms in foods (Goodridge, Willford & Kalchayanand, 2006), and the 
technology is now commercially available for food preservation (Jofré, Aymerich, 
Grèbol & Garriga, 2009; Ross, Griffiths, Mittal & Deeth, 2003; Torres & Velazquez, 
2005).   
 
HHP is governed by Le Chatelier‟s principle, which predicts that pressure favours 
processes accompanied by negative volume changes and conversely inhibits 
processes accompanied by positive volume changes.  As far as pressure is of 
biotechnological interest, it does not have any effect on covalent bonds, and as a 
result natural compounds such as aromas, dyes and flavours are not destroyed by 
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high pressure at room temperature (Masson et al., 2001), resulting in minimally 
processed food with the organoleptic properties intact.  HHP in many instances 
results in a better equilibrium between food safety on the one hand and food 
quality on the other (Van der Plancken, Grauwet, Oey et al., 2008).  The key 
advantages of HHP can be summarised as follows: food processing is possible at 
ambient temperature or lower; pressure is transmitted instantaneously through the 
system, irrespective of geometry or size; the use of chemical preservatives or 
additives can enhance microbial inactivation; and food with novel functional 
properties can be created (Rastogi et al., 2007). 
 
Inconsistencies seem to exist between the results produced by different 
researchers, and these were highlighted in a paper published by Balasubramaniam 
et al. (2004).  The difficulty in comparing the effects of process treatments on 
micro-organisms can be attributed to: differences in reporting the data, making it 
difficult and/or impractical to compare results; differences in process equipment 
design and configuration; inadequate description of experimental methodologies; 
lack of definitions and understanding of the process parameters, resulting in a non-
uniform process; and the influence of variable food matrixes on the inactivation and 
survival growth recovery of micro-organisms.  [Table 3.1 illustrates some of the 
inactivation profiles of HHP on pathogenic food-borne micro-organisms]. 
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Table 3.1  Inactivation profiles of some of the pathogenic bacteria associated with food-borne diseases 
 
   
Treatment parameters 
 
Reference Organism Suspending medium Pressure 
(MPa) 
Time 
(minutes) 
Temp 
(ºC) 
Log 
reduction 
Koseki, Mizuno and Yamamoto 
(2008) 
Listeria monocytogenes Milk 550 5 25 Undetectable 
Kural, Shearer, Kinglsey and 
Chen (2008) 
 
Kural and Chen (2008)   
Vibrio parahaemolyticus 
 
V. vulnificus 
 
Oysters 
Oysters 
Oysters 
Oysters 
≥350 
≥300 
150 
150 
2 
2 
4 
4 
1-35 
40 
1ºC 
20 
5 
5 
2.8 
0.5 
Viazis, Farkas and Jaykus 
(2008) 
Staphylococcus aureus 
ATCC 6538 
Staph. aureus ATCC 
25923 
E. coli ATCC 25922 
L. monocytogenes ATCC 
19115 
Milk 
Milk 
Milk 
Milk 
400 
400 
400 
400 
30 
30 
30 
2 
21-31 
21-31 
21-31 
21-31 
6 
8 
6 
8 
Chen (2007) L. monocytogenes Turkey meat 
Turkey meat 
500 
500 
1 
1 
40 
20 
3.8 
0.9 
López-Pedemonte, Roig-
Sagués, De Lamo et al. (2007) 
L. monocytogenes NCTC 
11994 
 
L. monocytogenes 
Scott A 
Cheese 
Cheese 
Cheese 
Cheese 
400 
500 
400 
500 
10 
10 
10 
10 
20 
20 
20 
20 
2.9±0.2 
5 
1.5±0.2 
5 
Gao, Ju and Jiang (2006) Staph. aureus As 1.2465 Milk 329.8 15.5 34.5 6 
Smiddy, O‟Gorman, Sleator et 
al. (2005) 
E. coli PBS 
Oysters 
PBS 
200 
400 
400 
5 
5 
5 
20 
20 
20 
no reduction 
1 
3 
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With regard to HHP treatment, Listeria monocytogenes and Staphylococcus 
aureus are two pathogenic non-spore-forming Gram-positive bacteria that have 
been subjected to thorough evaluation (Pilavtepe-Çelik, Buzrul, Alpas & Bozoğlu, 
2008).  The response of these bacteria to different combinations of treatment 
parameters (Wuytack, Diels & Michiels, 2002), food matrixes (Pilavtepe-Çelik et al., 
2008), pH (Alpas, Kalchayanand, Bozoğlu & Ray, 2000), antibiotics (Black, Kelly & 
Fitzgerald, 2005) and bacteriocins (Alpas & Bozoğlu, 2000) are well documented.  
Some of these studies also documented the variation in pressure resistance 
among the different strains of Listeria monocytogenes and Staphylococcus aureus 
(Alpas, Kalchayanand, Bozoğlu et al., 1999).   
 
 
3.3 OYSTERS (CRASSOSTREA) 
As the consumption of shellfish and seafood has increased worldwide, so has the 
incidence of associated outbreaks of bacterial and viral illnesses (Smiddy et al., 
2005; Teplitski, Wright & Lorca, 2009).  Oysters (Crassostrea) are bivalve filter-
feeding molluscs, passing large amounts of water through their gills to obtain food 
and oxygen from the environment (Cliver, 1995).  The quality of oysters is thus 
dependent on the environment (marine and estuarine water) in which they grow 
and feed.  Raw oysters represent an important vector of pathogens and marine 
biotoxins due to their ability to bioconcentrate pathogens and toxins through filter-
feeding (Rippey, 1994).  Oysters are typically consumed raw or slightly cooked and 
are ingested whole (including the intestines), a fact that increases the risk of food-
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borne diseases especially when the molluscs originate from a contaminated 
aquatic habitat or are handled under precarious hygienic conditions (Pereira, 
Nunes, Nuernberg et al., 2006), leading to post-harvest contamination.  The use of 
post-harvest treatments is effective in inactivating shellfish-associated pathogens, 
but most of these treatments also kill the molluscs in the process.   
 
HHP processing is increasingly being employed in the commercial processing of 
oysters due to its minimal effect on sensory and nutritional quality, as well as 
additional beneficial effects such as shucking and increased tissue yields.  The 
effects of HHP on micro-organisms and seafood are dependent on processing 
parameters, and the intricate nature of HHP necessitates the careful design of 
processing regimes to exploit the goals of microbial and enzyme inactivation, whilst 
maintaining optimum product quality (Cruz-Romero, Smiddy, Kerry & Kelly, 2004, 
Murchie, Cruz-Romero, Kerry et al., 2005).  Some of the bacterial genera 
associated with shellfish contamination are Escherichia (Brasher, DePaola, Jones 
& Bej, 1998), Listeria (Monfort, Minet, Rocourt et al., 1998), Vibrio (Cook, 2003), 
Salmonella (Brands, Billington, Levine & Joens, 2005), Staphylococcus (Pereira et 
al., 2006), Pseudomonas, Shewanella, Enterobacter and Serratia (Cruz-Romero, 
Kelly & Kerry, 2008). 
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3.4 LISTERIA MONOCYTOGENES 
Listeria monocytogenes are Gram-positive bacilli able to survive environmental 
conditions that are usually fatal to other micro-organisms (Cunningham, O‟Byrne & 
Oliver, 2009).  The organism is a facultative anaerobic bacillus capable of growth 
at temperatures ranging from 1 ºC to 45 ºC, tolerating high salt concentrations and 
acidic pH (Murray, Rosenthal & Pfaller, 2009).  Listeria monocytogenes is a 
ubiquitous organism occurring in terrestrial and aquatic habitats (Karunasagar & 
Karunasagar, 2000) and this has led to its presence in the food-processing 
environment and the food chain.  The ability of this organism to proliferate at 
refrigerator temperature (Hain, Chatterjee, Ghai et al., 2007) enables this pathogen 
to remain on contaminated foods and establish infection after ingestion 
(Cunningham et al., 2009).  It is a food-borne bacterial pathogen and the causative 
agent of listeriosis, a severe disease with high hospitalisation and fatality rates 
(Gandhi & Chikindas, 2007) and it is notorious for affecting high-risk subgroups of 
the population (Tauxe, 2002).  The overt form of listeriosis has a mortality rate of 
circa 20 percent (Churchill, Lee & Hall, 2006), while the mortality rate of 
symptomatic listeriosis is higher than that of any other food-borne disease (Murray 
et al., 2009).  Several studies have focused on the presence of Listeria 
monocytogenes or Listeria spp. in shellfish and seafood (Elliot & Kvenberg, 2000; 
Karunasagar & Karunasagar, 2000; Parihar, Barbuddhe, Danielsson-Tham & 
Tham, 2008; Wan Norhana, Poole, Deeth & Dykes, 2009), although data also 
suggests that Listeria spp. are not detectable in shellfish (Minami, Chaicumpa, 
Chongsa-Nguan et al., 2009).  The incidence of Listeria spp. in live shellfish must 
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therefore be known if one is to evaluate the actual role of secondary cross-
contamination and bacterial multiplication in the microbiological quality of marketed 
shellfish (Laciar & De Centorbi, 2002).  
 
 
3.5 STAPHYLOCOCCUS AUREUS 
The Gram-positive Staphylococcus aureus are catalase- and coagulase-positive, 
non-sporing bacteria able to grow in media with a high salt concentration (up to 10 
percent sodium chloride) and at temperatures ranging from 18 ºC to  40 ºC (Murray 
et al., 2009).  Staphylococcus aureus is ubiquitous in humans and animals, and it 
is estimated that circa 20 percent of healthy individuals are persistent carriers and 
60 percent are intermittent carriers (Bamberger & Boyd, 2005). 
 
Food-borne diseases are a major concern across the world.  Approximately 250 
different food-borne diseases have been described, with bacteria being the 
causative agents of two thirds of these food-borne disease outbreaks (Le Loir et 
al., 2003).  Staphylococcus aureus is one of the most prevalent food-borne 
bacterial pathogens (Chokesajjawatee, Pornaem, Zo et al., 2009) and a leading 
cause of gastroenteritis resulting from the consumption of contaminated food (Le 
Loir et al., 2003).  Staphylococcal food poisoning is caused by the ingestion of 
staphylococcal enterotoxins that were pre-formed in the implicated food 
(Chokesajjawatee et al., 2009), causing intoxication rather than infection (Murray et 
al., 2009).  Staphylococcal enterotoxins are produced during all phases of growth, 
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but mostly during the middle and at the end of the exponential phase (Soriano, 
Font, Molto & Mañes, 2002).  Various food sources have been implicated as the 
culprit in food-poisoning outbreaks, including meat, poultry, Minas cheese and raw 
milk (Do Carmo, Dias, Linardi et al., 2002), “Bgalla” (fried potato balls) (Nema, 
Agrawal, Kamboj et al., 2007), dairy products (Veras, Do Carmo, Tong et al., 2008) 
and fish and shellfish (Wieneke, Roberts & Gilbert, 1993; Ayulo, Machado & 
Scussel, 1994; Cao, R., Xue, C-h. & Liu, Q. 2009).   
 
The food matrix, the microbial species, and the ability of psychrotrophic micro-
organisms to recover in food products are critical factors when evaluating the 
efficacy of HHP treatment (Jofré et al., 2009).  Bearing in mind that oysters are 
pressured in the region of 200 MPa, which is sufficient to shuck the oysters and 
inactivate various Vibrio species and some viruses, Listeria monocytogenes and 
Staphylococcus aureus were selected as possible pathogenic contaminants in 
shellfish for purposes of this study on high-pressure treatment.  With this study the 
authors explored the response of Listeria monocytogenes (obtained from the Unit 
for Applied Food Science and Biotechnology culture collection (UAFSBCC), 
Central University of Technology, Free State, South Africa) and Staphylococcus 
aureus (ATCC 25923) to 200 MPa, by employing different enumeration methods to 
assess cell damage and evaluate the growth phases (surviving cells) so as to shed 
light on subsequent cellular repair after sub-lethal injury.  
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3.6 MATERIALS AND METHODS 
Refer to chapter 2 (sections 2.4.1-2.4.5;  p63-66) for materials and methods 
description on the propagation and enumeration of the organisms, high pressure 
equipment and treatment, and statistical analysis. 
 
 
3.7 RESULTS 
Listeria monocytogenes (UAFSBCC) and Staphylococcus aureus (ATCC25923) 
suspensions were subjected to pressure of 200±5 MPa for 15 minutes, with the 
starting temperatures of the samples at 8 ºC and 50 ºC.  No significant differences 
(P≥0.05) with any of the treatment parameters were observed when compared to 
the controls and as a result values were expressed as percentage difference.  
Refer to chapter 2 (p65-66) for calculation of percentage difference. 
 
A PD of <25 percent was considered to be within experimental variability.  A 
positive percentage value indicates that growth of the test organism (pressurised) 
was weaker than that of the control, with a negative value indicating the opposite 
(this is applicable to all the enumeration parameters).  [Table 3.2 gives an outline 
of the percentage differences]. 
 
 
3.7.1 Colony-Forming Units 
For Listeria, notable PDs (82 and 67) were observed at six hours at both treatment 
 96 
 
 
 
 
Table 3. 2 Results of the percentage differences observed for each of the treatment procedures (200 MPa 15 min-1) 
 
                 
  
Difference (%) 
Comparison 
with control  
(P≤0.05) 
  
Treatment 
temp (ºC) 
0 H 6 H 18 H 24 H 30 H 42 H 48 H 
 
CFUs  8
L
 13 82 21 33 16 10 21 0.354 
 50
L
 -28 67 42 10 15 8 6 0.408 
 8
S
 28 18 9 18 29 -348 -35 0.209 
 50
S
 -360 -277 8 13 7 43 24 0.193 
         
 
ICC  8
L
 19 44 1 -16 -19 6 10 0.416 
 50
L
 19 11 4 -7 2 -10 7 0.471 
 8
S
 9 37 20 27 15 7 2 0.353 
 50
S
 -10 -31 -76 -38 15 6 -22 0.35 
         
 
OD  8
L
 5 70 -8 -8 -5 -1 2 0.401 
 50
L
 4 56 -6 -5 -4 -0.9 3 0.434 
 8
S
 1 21 0.3 2 0.2 0.02 0.4 0.479 
 50
S
 1 -146 -4 2 -3 -0.3 0.2 0.483 
CFUs – colony-forming units; ICC – intact cell count; OD – optical density; H – Time (hours); 
L – Listeria monocytogenes; S – Staphylococcus aureus 
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temperatures, becoming slightly elevated after 18 hours at 50 ºC and after 24 
hours at 8 ºC.  PDs observed after 30-48 hours at both treatment temperatures 
were not significant.  Furthermore, Staphylococcus showed notable PDs at zero (-
 360) and six (-277) hours at 50 ºC and a PD of -348 at 8 ºC after 42 hours, 
indicating that the test cells proliferated at a more rapid rate than the control cells.  
No significant PD for the 50 ºC treatment was observed in the case of 
Staphylococcus. 
 
 
3.7.2 Intact Cell Count 
For Listeria a notable difference (44) was only observed at six hours for the 8 ºC 
treatment.  However, Staphylococcus had slightly elevated PDs after six (37) and 
24 (27) hours at 8 ºC, while in the case of the 50 ºC treatments, elevated PDs were 
observed at six (-31), 18 (-76) and 24 (-38) hours, indicating a higher proliferation 
rate for the test cells. 
 
 
3.7.3 Optical Density 
As was observed with the CFU, a notable PD (70 and 56) was observed at six 
hours for Listeria at both treatment temperatures.  Staphylococcus showed a 
notable difference at six (-146) hours at 50 ºC, while the same trend was observed 
in the case of CFU and ICC, indicating an increased proliferation of the test cells. 
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3.8 DISCUSSION 
HHP is a preservation technology that has received much attention in recent years.  
It involves the application of pressures ranging from 100 to over 1 000 MPa at 
temperatures varying from 0-100 ºC and holding times varying from seconds to 
several minutes (Ramaswamy, Balasubramaniam & Kaletunç, 2006).  Viability loss 
of pathogens is enhanced considerably as the pressure level and temperature 
increase (Alpas et al., 2000).  When high pressure is applied to a food product, 
different reactions will occur, i.e. micro-organisms are inactivated, enzyme activity 
is enhanced or diminished, and chemical compounds are formed or destroyed 
(Van der Plancken et al., 2008).  
 
In this study Listeria monocytogenes and Staphylococcus aureus were subjected 
to HHP at 200 MPa, and recovery of surviving pressurised cells was facilitated by 
incubation in buffered peptone water.  Normally, the pressurisation of organisms 
results in their injury or death; however, this is governed by the species and strain 
of the organism, as well as pressure levels, temperatures and subsequent storage 
conditions.  Following pressurisation in the late exponential phase (after 16 hours 
of incubation), the cells initiated growth with a short (six-hour) lag phase, followed 
by exponential growth for up to 48 hours and subsequent stationary-phase growth.  
 
Significant PDs (end of lag phase) at six hours were only observed for Listeria 
monocytogenes at both temperatures, indicating sub-lethal injury of the bacterial 
cells and denoting the channelling of an increased amount of energy towards 
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metabolic adaptation (recovery) rather than growth.  It would seem that 
Staphylococcus aureus (exponential cells) was even more resistant to HHP, 
especially at shucking pressures, as the PDs observed at all treatment parameters 
were not significantly high.  This supports the finding of Arroyo, Sanz and 
Préstamo (1999) that cocci are more pressure resistant than bacilli.  The reduced 
cell surface area of cocci in contact with the environment minimises the effect of 
high pressure (Arroyo et al., 1999).   
 
The conditioning temperatures of 8 ºC and 50 ºC respectively for five minutes and 
subsequent pressurisation at these temperatures did not seem to have a significant 
influence on percentage differences.  However, in this study, the cells were 
incubated at 37 ºC prior to conditioning; different results might be observed if 
incubated at a suboptimal temperature, inducing heat/cold shock (Serrazanetti, 
Guerzoni, Corsetti & Vogel, 2009).  Another contributing factor to the limited 
differences between the control/test cells could be that the treatment temperatures 
of 8 ºC and 50 ºC respectively were not maintained for the duration (15 minutes) of 
the pressurisation, and this had a negative effect on bacterial inactivation.  
Staphylococcus aureus test cells proliferated much better than the control cells, as 
was observed with CFU, ICC and OD at six hours at the 50 ºC treatment 
temperature.  This could indicate that the prolonged exposure (20 minutes) of the 
control cells to the elevated temperature resulted in pronounced stress in the 
controls cells, causing the test cells to proliferate better despite being subjected to 
HHP. 
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Although HHP is known to induce damage that could result in cell death, it would 
seem that Listeria monocytogenes was able to repair pressure damage and then 
continue to proliferate (extended lag phase).  The slight variances observed in the 
PDs of the CFUs and ICC could be attributed to the physiological status and age of 
the cell.  From the results it would seem that cellular repair occurred mostly within 
18 hours of incubation.   
 
In view of the insignificant PDs observed with optical density determinations, it 
would seem that different treatment temperatures (8 ºC and 50 ºC) had no effect 
on Staphylococcus aureus.  The notable PDs observed after six hours for Listeria 
monocytogenes in all the treatment parameters are most likely to be the result of 
the restoration of growth capabilities.  Thereafter cellular adaptation as determined 
by OD seems to have been completed after 18 hours.  Sub-lethal HHP resulted in 
a more pronounced metabolic adaptation or structural correction rather than a 
morphological change as in the case of Listeria monocytogenes. 
 
From the results it can be concluded that sub-lethally injured micro-organisms 
could still present a latent hazard in food safety given that they are able to repair 
themselves under favourable conditions.  Preservation methodologies ought to rely 
on a combination of pre-harvest factors such as depuration and use of probiotics, 
and post-harvest factors such as preventing recontamination with pathogenic food 
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spoilage organisms prior to HHP for purposes of the successful decontamination of 
fresh oysters and the reduction of microbial counts.   
 
Concerning the microbiological safety of food, quantifying the inactivation of 
pathogens and spoilage bacteria is imperative and critical in the establishment of 
an effective HHP treatment regime, and requires an understanding of microbial 
physiology and behaviour of the cells before, during and after HHP treatment.  The 
target organisms in food preservation are for the most part vegetative organisms 
with various growth requirements.  The storage conditions, selection of the 
recovery medium (selective vs. enriched) and subsequent culturing conditions will 
therefore determine the count of the surviving organisms and/or the recovery of the 
sub-lethally injured organisms.  When assessing the efficacy of any HHP treatment 
regime, it is imperative that the most pressure-resistant organism is regarded as 
the target organism.  Within the conditions of this study, this proved to be 
Staphylococcus aureus.  Inactivation of the most resistant organism by HHP will 
thus result in inactivation of the less resistant organisms as well.  In the instance 
where pressurisation of 200 MPa was applied, it is evident that Listeria and 
Staphylococcus were not optimally inactivated or injured to render a sufficiently 
safe product for human consumption.  This treatment pressure can only be 
successfully applied to inactivate Vibrio species and shuck oysters.  Several 
studies have proven that a combined use of pressure and elevated temperature is 
necessary to inactivate Listeria and Staphylococcus and that heat treatment or 
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pressure treatment alone is not sufficient to significantly reduce the number of 
organisms (Bozoğlu, Alpas & Kaletunc, 2004; Jofré et al., 2009).   
 
Sub-lethal injury of Listeria could be adequate if combined with hurdles such as 
suboptimal growth conditions to extend the shelf-life of the product.  However, 
since oysters are stored at refrigeration temperatures, psychrotrophic Listeria could 
have an opportunity to proliferate, thereby rendering the product unsafe and 
infectious to humans.  Viable toxigenic micro-organisms such as Staphylococcus 
aureus can form toxins in food, but are harmless if inactivated by HHP.  Sub-lethal 
injury of this organism by means of pressurisation at 200 MPa and subsequent 
refrigeration storage could result in this organism surviving at these lower 
temperatures and resuming growth when temperature conditions are once again 
favourable, resulting in the production of staphylococcal enterotoxins that render 
the product toxic.  To ensure the microbiological safety of Crassostrea it is of the 
utmost importance to inactivate any pathogens, and as long as there is a market 
for fresh, live, raw oysters, researchers and food scientists can explore the effects 
of HHP as a preservation methodology. 
 
It is a known fact that HHP modifies the structure of some proteins and the activity 
of some enzymes.  Even though covalent bonds are not affected, hydrogen bonds 
as well as hydrophobic and intermolecular interactions may be modified or 
destroyed (Rastogi et al., 2007).  However, little is known about the effects of HHP 
on the lipoteichoic acid (LTA) structure of Gram-positive organisms.  Further 
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studies should be conducted to assess the virulence of post-HHP Listeria 
monocytogenes and Staphylococcus aureus, as metabolic adaptation and cell 
repair might also have an impact on the LTA structure, the ability to form biofilm, 
and pyrogenicity. 
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4. IN VITRO QUANTIFICATION OF ESCHERICHIA COLI O111 
LIPOPOLYSACCHARIDE TOXICITY SUBSEQUENT TO SUBLETHAL 
HIGH HYDROSTATIC PRESSURE 
 
4.1 ESCHERICHIA COLI  
It is well known that micro-organisms damaged (injured) by food preservation 
methodologies could influence the accuracy of standard quality control 
assessments.  During the latter, micro-organisms are frequently cultivated under 
stressful conditions (selective media) that select not only for specific organisms but 
also for “healthy” organisms within this group.  Therefore, although organisms 
injured during food processing with high hydrostatic pressure (HHP) might yield a 
false negative result, within the processing line or final product they might 
regenerate viability (heal) to colonise or spoil the end product.  Among these 
organisms are the ubiquitous Escherichia coli group of organisms, which include 
both pathogenic and non-pathogenic strains.   
 
The pathogenic strain E. coli O111 is responsible for enterohaemorrhagic and 
enteropathogenic diseases in humans (Nataro & Kaper, 1998) and is of special 
concern in developing countries where it is a classic cause of diarrhoea in children.  
Infections from an enterohaemorrhagic E. coli (EHEC) strain may result from 
contact with infected animals (especially cattle), beef products and their faeces 
(Armstrong, Hollingsworth & Morris, 1996), and consumption of contaminated 
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foodstuffs, including fruits and vegetables such as cantaloupe (Feng 1995), lettuce 
(Ackers, Mahon, Leahy, Goode et al., 1998), apple cider (Besser, Lett, Weber, 
Doyle et al., 1993) and potatoes (Morgan, Newman, Palmer, Allen et al., 1988).  
Furthermore, the infectious dose of shiga toxin-producing E. coli O111 is low, as 
was observed with an STEC O111;H- outbreak in Australia where the implicated 
fermented sausages contained fewer than one E. coli O111 organism per 10g 
(Paton, Ratcliff, Doyle, Seymour-Murray et al., 1996).   
 
 
4.2 HIGH HYDROSTATIC PRESSURE  
Nonthermal food-processing procedures were designed to eliminate the use of 
elevated temperatures during processing, avoiding the adverse effect of heat on 
the nutritive value, flavour and appearance of foods (Barbosa-Canovas, Gongora-
Nieto, Pothakamury & Swanson, 1999).  There are several additional benefits 
when combining high temperature conditions with nonthermal processes; however 
the use of high heat negates the innovative aims of nonthermal processing 
(Ohlsson, 1994).  Pressure is an important thermodynamic variable and can disturb 
a wide range of biological structures and processes if it is significantly changed 
from the normal conditions established in the biosphere (Earnshaw, Appleyard & 
Hurst, 1995).  At low or moderate temperature, HHP causes destruction of 
microbial vegetative cells and enzyme inactivation, without changing the 
organoleptic characteristics of the product and leaving the vitamins intact.  The 
efficacy of the treatment also depends on the achieved pressure, treatment 
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temperature and exposure time.  Food matrix and micro-organism resistance must 
also be taken into consideration.  HHP treatment can induce special effects on the 
texture and structure of a given food and can be used for the development of new 
products or to improve the functionality of some ingredients (Hugas, Garriga & 
Monfort, 2002).  Loss of bacterial cell viability begins at approximately 180 MPa, 
and the rate of inactivation increases exponentially as the pressure increases 
(Hauben, Wuytack, Soontjes & Michiels, 1996).  Inactivation of micro-organisms by 
HHP is undoubtedly the result of a combination of factors; therefore cell death is 
attributed to accumulated damage inside the cell and not just a singular event 
(Simpson & Gilmour, 1997). 
 
 
4.3 LIPOPOLYSACCHARIDES  
Bacterial lipopolysaccharides, (endotoxins) are the main components of the outer 
membrane of E. coli O111, a Gram-negative bacterium (Caroff & Karibian, 2003; 
Wilkinson, 1996) and may exist as free and cell-wall bound (Mattsby-Baltzer, 
Lindgren, Lindholm & Edebo, 1991).  LPS‟s are a unique class of macromolecules 
representing intrinsic cell-wall components of Gram-negative bacteria (Zubova, 
Melzer & Prokhorenko, 2005).  Refer to chapter 1 for structural details on LPS. 
 
It is well known that lipid A is the “endotoxic principle” of the molecule, and the 
biological activity of lipid is influenced by the fatty acid content, whereby a reduced 
amount of fatty acids in long-chain LPS may affect the biological activity (Mattsby-
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Baltzer et al., 1991).  The reaction of the Limulus amebocyte lysate (LAL) assay is 
dependent on the chemical and physiochemical structure of the endotoxin 
(Rietschel, Brade, Brade, Brandenburg et al., 1987).  Each species of bacteria has 
a specified lipid A structure, which is closely associated with endotoxin activities 
such as pyrogenicity and lethality (Ogikubo, Norimatsu, Noda, Takahashi et al., 
2004).  Brandenburg, Jürgens, Andrä, Lindner et al. (2002) showed that the 
diglucosamine-4‟-phosphate region in the lipid A moiety of LPS is the binding 
epitome in the LAL assay.  However, inactive compounds such as tetra- and penta-
acyl lipid A also exhibit high LAL activity (Schromm, Brandenburg, Loppnow, 
Moran et al., 2000).   
 
Whereas LPS liberated from the outer membrane of Gram-negative bacteria 
remains the prototypic pyrogen, substances such as lipoteichoic acid (LTA) and 
peptidoglycan from Gram-positive bacteria (Daneshian, Guenther, Wendel, 
Hartung & Von Aulock, 2006), fungal spores (Tran, Ahmad, Xu, Ahmad & 
Menezes, 2003) and viral pathogens (Bowie & Haga, 2005) are now also 
recognised as powerful immune stimuli.  As they are derived from the external 
environment of the body, they are called exogenous pyrogens (Zeisberger, 1999).  
Pyrogen is derived from the Greek word “pyros” meaning “fire” (Daneshian, 
Wendel, Hartung & Von Aulock, 2008), and pyrogens are fever-inducing 
substances usually derived from different pathogenic stimuli (Daneshian et al., 
2006).  Moreover, LPS‟s are of interest in medicine, for they are strong 
immunomodulators in the infected host and elicit a variety of pathophysiological 
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effects such as endotoxic shock, tissue injury and lethality (Caroff. Karibian, 
Cavaillon & Haeffner-Cavaillon, 2002; Ogikubo et al., 2004).  In addition to LPS‟s 
being amongst the most potent activators of the mammalian immune system, they 
are also essential for the viability of Gram-negative bacteria.   
 
 
4.4 LIMULUS AMOEBOCYTE LYSATE 
The LAL assay is widely used as an in vitro alternative to the labour-intensive in 
vivo rabbit pyrogen test for the detection and quantification of endotoxins in food 
and pharmaceutical products.  There are, however, a few drawbacks: it does not 
exactly parallel in vivo pyrogenic activity but rather reflects the amount of LPS 
(Lee, Sung, Han, Lee et al., 2005), other pyrogenic stimuli are not detected, and 
numerous substances interfere with the assay, e.g. potassium chloride, sodium 
chloride, sodium bicarbonate and acetic acid (Bohrer, Hörner, Do Nascimento, 
Adaime et al., 2001; Daneshian et al., 2008).  The LAL utilises lysate of the blood 
cells of the arachnid, the horseshoe crab, which enzymatically interacts with 
endotoxins and is used to detect the presence of endotoxins in many different 
samples (Bohrer et al., 2001, Daneshian et al., 2006).   
 
Variations in temperature, nutrient availability and exposure to stressors such as 
HHP and sanitizers (Venter, Abraham, Lues and Ivanov, 2006a) require an 
adaptive response for bacterial cells to survive.  For E. coli O111, exposure to 
stressors can result in the activation of one or more stress responses that are 
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compartmentalised and managed by specialised systems (McBroom & Kuehn, 
2007).  Numerous studies have investigated the effect of different conditions (pH, 
temperature, time, antimicrobials, etc.) in combination with HHP on the viability of 
micro-organisms; however, as far as is known, no such studies have investigated 
the possible effect of HHP on LPS toxicity.   
 
Gram-negative bacteria spontaneously release LPS‟s in the form of vesicles during 
normal cell growth (Horstman & Kuehn, 2000), and the rate of release varies 
among different bacterial species and strains (Russel, 1976).  These vesicles may 
also contribute to pathogenicity by serving as vehicles for toxins to encounter host 
cells (Horstman & Kuehn, 2000).  E. coli are part of the normal biota in human and 
animal intestinal tracts, and some strains of E. coli exhibit pathogenicity towards 
the human body.  It is therefore important to monitor and determine the presence 
of this organism and its products (LPS) in food and clinical medicine and the 
general environment (Qu, Bao, Su & Wei, 1998).   
 
Considering that oysters are pressured in the region of 200 MPa, which is sufficient 
to shuck the oysters and inactivate various Vibrio species and some viruses, E. coli 
O111 was selected for this high-pressure study because it is an emerging 
pathogenic contaminant in shellfish.  It is further known that injured E. coli O111 
cells are able to repair membrane damage and proliferate when cultured in 
enriched medium after sublethal HHP (Olivier & Venter, 2009).  This study 
investigated the influence of sublethal HHP at 8 and 50 ºC respectively for 15 
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minutes at 200 MPa on the LPS toxicity of E. coli O111 as measured by a 
chromogenic LAL assay.  
 
 
4.5 MATERIALS AND METHODS 
Refer to chapter 2 (sections 2.4.1 - 2.4.3; p63-64) for materials and methods 
description on the propagation of the organisms, high pressure equipment and 
treatment. 
 
 
4.5.1 Lipopolysaccharide Extraction 
After high hydrostatic pressure treatment the samples were subcultured by 
inoculating 100 µl of the sample in 150 ml buffered peptone water and incubated at 
37 °C with agitation.  Subsequently LPS extraction was performed at 0 hours 
(immediately after pressurisation) and again at 6, 18, 24, 30, and 48 hours.  LPS 
were extracted by means of a combination of the methods of Folch, Lees and 
Sloane-Stanley (1957) and Venter and Ivanov (personal communiqué).  Five 
millilitres of each of the test and control culture broths were aliquoted in pyrogen-
free tubes (Nunc, AEC Amersham, South Africa) and centrifuged for 30 minutes at 
4 000 rpm (J.P. Selecta s.a., Mixtasel).  Circa 4.5 ml of the supernatant (with free 
LPS not bound to cells) (about 4.5 ml) were aseptically removed and aliquoted in 
pyrogen-free tubes for LPS separation.  Equal amounts of the supernatant (±4,5 
ml) and chloroform-methanol (2:1; v/v) (Merck, SA) were mixed on a vortex and 
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stored overnight at 4 ºC to separate into a biphasic system with LPS with reduced 
lipid content in the upper phase (aqueous) and LPS with increased lipid content in 
the lower phase (organic). 
 
The pellet (from the original centrifuged samples expected to contain the cell-
bound LPS) was resuspended in sterile saline and washed three times with the 
saline.  A similar extraction method to that mentioned was performed on the pellet.  
The two phases were separated and concentrated by rotary evaporation (IKA 
WERKE, PV06ML, GMBH & CO. KG) with a bath temperature of 46 ±2 ºC.  The 
sides of the evaporation tubes were rinsed with either 400 µl methanol (aqueous 
phase) or 1 ml chloroform (organic phase) (depending on the phase) and the 
respective concentrates were then transferred to pyrogen-free sample vials.  
Samples were dried for four hours in a vacuum oven (Shinha JCS) at 40 ºC under 
maximum vacuum and reconstituted with 1 ml of pyrogen-free water before LAL 
analysis was performed. 
 
 
4.5.2 Limulus Amoebocyte Lysate Assay 
LPS toxicity on all the extracted LPS samples was determined using the 
chromogenic LAL, which is a quantitative test for Gram-negative bacterial 
endotoxin (CAMBREX, QCL-1000, Limulus Amoebocyte Lysate, WhiteSci, SA).  
The test was performed by the microplate method as prescribed by the 
manufacturer.  The test kits included E. coli endotoxin standards with 
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approximately 15-40 endotoxin units (EU) lyophilised endotoxins.  Endotoxin 
standards ranging from 0.1 to 1.0 EU ml-1 were prepared and a standard curve was 
constructed by plotting OD410 nm against the EU per absorbance unit.  The 
absorbance of the released p-nitroaniline (yellow colour) from the synthetic 
substrate was read at 410 nanometre (nm) with a microplate reader (Bio-Rad 680).  
Endotoxin concentration in the samples was determined by the graphic method 
proposed by the manufacturer.  All equipment, reagents and consumables used 
were pyrogen free. 
 
 
4.6 RESULTS AND DISCUSSION 
LPS biosynthesis underlies quantitative differences in the bacterial growth phases, 
which results in changes in the endotoxin content of the cells, and therefore values 
were calculated as [toxicity]/OD620nm, and not viability (Venter, Abraham, Lues & 
Ivanov, 2006b).  Thereafter the differences at unit time intervals were considered 
and presented as the percentage difference (PD).  Refer to chapter 2 (p66) for 
calculation of percentage difference. 
 
A positive percentage value indicates that the toxicity of the test organism 
(pressurised) was less than that of the control (non-pressurised), while a negative 
value indicates the opposite (this is applicable to all the enumeration parameters).  
PDs lower than 200 were considered to be within experimental variation.  [Table 
4.1 shows an outline of the percentage differences].  
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Table 4.1 Percentage differences in toxicity of E. coli O111 LPS observed for 
each of the treatment procedures (HHP at 200MPa 15 min-1) 
 
  Percentage difference 
  
Treatment 
temp (ºC) 
0 H 6 H 18 H 24 H 30 H 48 H 
ST, OP 8
a
 475 -160 -17 27 -4 7 
ST, AP 8
a
 -47 -160 -40 65 138 80 
ST, OP 50
a
 -6 -3701 -25 -72 -65 -46 
ST, AP 50
a
 -65 -3787 3 -43 11 36 
        
PT, OP 8
a
 81 192 -21 -4 -24 118 
PT, AP 8
a
 -52 -296 12 -85 1 -4 
PT, OP 50
a
 -181 4658 157 -92 1306 103 
PT, AP 50
a
 21 -1426 2 -31 33 33 
        
ST, OP 8
b
 -3 -187 176 -222 203 469 
ST, AP 8
b
 40 -179 -41 -10 -50 7 
ST, OP 50
b
 -6 -96 -23 -105 137 223 
ST, AP 50
b
 -4 -2438 22 0.8 1 55 
        
PT, OP 8
b
 65 236 82 72 21 -142 
PT, AP 8
b
 23 42 -39 -15 10 13 
PT, OP 50
b
 -27 -35 -16 466 -621 -19 
PT, AP 50
b
 7 -29 -0.5 0.0 -26 -69 
ST - supernatant; PT – pellet; OP - organic phase; AP - aqueous phase; H - time (hours) 
(
a
) - low bacterial load; (
b
) - high bacterial load 
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In this study E. coli O111 was subjected to sublethal HHP treatment, and recovery 
of pressurised cells was facilitated by incubation in buffered peptone water.  When 
micro-organisms are exposed to HHP it is to be expected that they will be injured 
or killed.  This is, however, dependent on the species and the strain of bacteria, 
HHP conditions and subsequent storage.  Subsequent to injury, bacteria might 
regenerate during storage, which may have an effect on the microbiological quality 
of foodstuffs (Bozoğlu, Alpas & Kaletunç, 2004), not only as an infectious agent but 
as a toxic product as well.  
 
Cells that are only sublethally injured by HHP have the capacity to repair the site of 
injury (Russel, 2002) and return to a normal physiological state with initiation of 
growth and cell division under favourable conditions (Hurst, 1984), thus liberating 
LPS as a result of division, vesicle formation and death (Cadieux, Kuzio, Milazzo & 
Kropinski, 1983; Horstman & Kuehn, 2000).  Bacteria from the late exponential 
phase (after 14-16 hours of incubation) were pressurised and immediately 
subcultured in fresh medium.  The exponential growth phase commenced after six 
hours (all cells) of incubation followed by the stationary phase at 48 hours.  The 
toxicity of cell-wall-bound (pellet) and free (supernatant) LPS from cultures of 
E. coli O111 subjected to HHP was studied in vitro.  Repeated washings in 
physiological saline most probably removed the capsular polysaccharide 
(K antigens) prior to LPS extraction by chloroform:methanol, hence no interference 
from capsular material was expected in this study. 
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From the literature it is evident that free LPS can be detected within eight hours of 
growth in a culture medium (Bartková, Majtán & Ciznár, 1986).  Within the 
parameters of this study, however, free LPS was detected within six hours in the 
supernatant of both the low and high bacterial loads.  The biological activity of the 
free LPS in this instance seems to be higher for the 50 ºC treatment than that of 
the corresponding pellet LPS.   
 
The PDs observed between the supernatant of the low and high bacterial loads 
differed notably from that observed in the pellet.  Differences were observed after 
six hours of incubation in most cases; however, the differences seemed more 
pronounced within the 50 ºC treatment parameter with the exception for the pellet 
of the high bacterial load.   
 
It could be that in response to HHP stress, E. coli O111 produced long-chain LPS 
(hexa-acylated lipid A), thereby increasing LAL activity.  Chemical heterogeneity in 
the side-chain and the core regions could be influenced by HHP stress, resulting in 
the percentage differences observed.  It is possible that metabolic adaptation of the 
cells, as observed at six hours, resulted in an increased synthesis of 3-deoxy-D-
manno-octulosonic acid (Kdo), causing increased toxicity as observed at six hours 
(50 ºC) for the aqueous phases of the pellet and supernatant low bacterial loads 
and the supernatant high bacterial load.  Long-chain LPS‟s, however, are not the 
only determinant for LAL activity – it is a possibility that HHP-induced stress 
resulted in R-mutant activities, thus increasing LAL activity as was observed.  
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Variations in toxicity as seen in the results are a function of the physiological status 
of the cell in response to sublethal HHP and cell death.  Differences in the 
phosporyl group could also contribute to toxicity, where diphosphoryl lipid A 
(moderate toxicity) and complete R-LPS are the structures that display the highest 
level of toxicity.  This could explain the high toxicity observed at six hours for the 50 
ºC treatment – low bacterial load (both phases) and the 50 ºC high bacterial load.  
In the instances where toxicity was not as pronounced, monophosporyl lipid A (less 
potent) could be the contributing factor.   
 
HHP damage to the diglucosamine-4‟-phosphate region (binding epitopes for the 
LAL assay) could also inhibit LAL, as was observed at 0 hours (immediately after 
pressurisation) for the 8 ºC organic phase.  LPS is well known for its dual 
biochemical characteristic in that the polysaccharide portion is hydrophilic and the 
lipid portion is hydrophobic.  The supramolecular aggregate structure of lipid A 
could also have an influence on LAL expression, whereby conical molecules, which 
form cubic inverted aggregate structures, exhibit high endotoxin activity, as 
observed at six hours for the organic and aqueous phases of the 50 ºC treatments 
(supernatant high load), the 50 ºC pellet low bacterial load and the supernatant 
high bacterial load.  It is also possible that the lower toxicity as observed at 24 
hours (pellet high bacterial load) in the 50 ºC organic phase, at six hours (pellet low 
bacterial load) in the 50 ºC organic phase, and at 48 hours (supernatant high 
bacterial load) in the 8 ºC organic phase is the result of cylindrical molecules that 
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formed lamellar aggregate structures, resulting in lower toxicity expressed by the 
pressurised cells. 
 
In bacteria the production of 3-hydroxy fatty acids (3-OH FAs) differs within 
species.  The presence of 3-OH FAs is a result of Beta-oxidation (Venter, Kock, 
Kumar, Botha, Coetzee, Botes, Bhatt, Schewe & Nigam, 1997).  Lipid A formed as 
a result of lipid synthesis could result in less 3-OH FAs, leading to lower toxicity as 
observed at six hours with the pellet low bacterial load.  In the event of a stress 
condition (HHP), β-oxidation could become the principle supply of energy, 
mobilising the 3-OH FAs which then present as intermediates in the β-oxidation 
cycle.  The presence of more 3-OH FAs will therefore constitute a higher toxicity, 
as observed at six hours for both the supernatant low and high bacterial loads 
(organic and aqueous phases) and the pellet low bacterial load aqueous phase.   
 
From these results it can be concluded that the toxicity response of the pressurised 
cells to HHP damage at 50 ºC was more pronounced than that observed for the 
treatments at 8 ºC and more so in the organic phases.  This could be explained by 
the higher amounts of lipids soluble in the organic phases rather than in the 
aqueous phases.  In most cases, membrane repair seemed to be completed at 48 
hours, as differences in toxicity were no longer that apparent.  
 
A structural change in LPS could also influence the response of the immune 
system.  It is therefore necessary to investigate the influence of HHP on the 
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immunogenicity of LPS on whole blood cell cytokine expression (IL-6).  It is well 
known that the major target for bacterial inactivation by HHP is the membrane, and 
therefore the influence of HHP on the enzymes responsible for Kdo biosynthesis 
and membrane structure needs to be investigated further.  In addition, the 
relationship between the LPS structure and toxicity of E. coli O111 deserves further 
investigation.  GC-MS analysis of 3-hydroxy fatty acids could provide valuable 
information on the amounts of Gram-negative bacteria and the LPS in the 
extractions when performing a risk analysis of food preserved with HHP. 
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5. IN VITRO QUANTIFICATION OF PORCINE IL-6 INDUCED BY 
ESCHERICHIA COLI O111 LIPOPOLYSACCHARIDES EXPOSED TO 
SUBLETHAL HIGH HYDROSTATIC PRESSURE 
 
5.1 LIPOPOLYSACCHARIDES 
Lipopolysaccharides are the major outer surface membrane components present in 
Gram-negative bacteria and are potent immunostimulants to the innate or natural 
immunity in diverse eukaryotic species ranging from insects to humans (Alexander 
& Rietschel, 2001).  They are also of great importance in the pathophysiology of 
numerous disease processes (Erridge, Bennet-Guerrero & Poxton, 2002; Proctor, 
Delinger & Bertics, 1995).  Many cellular and extracellular elements that form part 
of a host response system of challenge by LPS have been identified and 
characterised (Elsbach, 2000).  Picomolar concentrations of LPS can be detected 
by the innate immune system, which then triggers the cellular response (Refer to 
chapter 1 for a description of the immune response) (Gioannini, Teghanemt, 
Zhang, Coussens et al., 2004).  LPS are an intoxicating stimulus for a variety of 
cells in vivo (epithelial cells, endothelial cells, leukocytes, platelets) and in vitro, 
which is comparable to bacterial infection and lethal shock (Day, Rubin, Vodovotz, 
Chow et al., 2006; Ulmer, Flad, Rietschel & Mattern, 2000; Wright, Ramos, 
Hermanowski-Vosatka, Rockwell, 1991).  This response can take place locally or 
systemically (Heumann & Roger, 2002) and it induces the production of large 
quantities of inflammatory cytokines and mediators, providing numerous antigenic 
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sites (Proctor et al., 1995).  LPS do not act directly against cells or organs, but 
instead through the activation of the human immune system, especially through 
monocytes and macrophages.  These cells release mediators such as tumour 
necrosis factor, interleukins and free radicals, which have a potent biological 
activity and are responsible for the adverse effects of LPS exposure (Martich, 
Boujoukos & Suffredini, 1993; Pabst & Johnston, 1989; Rietschel, Kirikae, Schade, 
Mamat et al., 1994).   
 
The signalling pathways alerting the host to the presence of LPS-bearing bacteria 
and free LPS are similar in vertebrates, insects and plants (Hoffmann, Kafatos, 
Janeway & Ezekowitz, 1999).  The innate immune system initiates host defence 
against invasive microbial pathogens using specific recognition mechanisms.  
Pattern-recognition systems are the base of innate immunity that has considerable 
specificity, being able to distinguish between “self” and pathogens (Heumann & 
Roger, 2002). The pathogen-associated molecular pattern (PAMP) is a familiar 
molecular pattern, which is highly conserved and invariant amongst bacteria 
(Janeway, 1989), and the LPS is representative of a PAMP.  The lipid A moiety of 
LPS represents the invariant pattern responsible for the proinflammatory effects of 
LPS.  The innate immune cells then recognise the PAMP through the Toll-like 
receptors (Fujihara, Muroi, Tanamoto, Suzuki et al., 2003). 
 
Lipopolysaccharides are amphiphilic molecules that form large aggregates in 
solution. The supramolecular structure of the aggregates is defined by the 
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arrangement and pattern of the acyl chains, which define the “endotoxic” 
conformation (Seydel, Haekins, Schromm, Heine et al., 2003) that correlates with 
the biological activity (Jerala, 2007).  The variability of LPS between different 
bacterial strains necessitates that the LPS receptors are targeted against the lipid 
A moiety, which is the minimal fragment that can trigger the cellular response, in 
order to give a response to a broad spectrum of Gram-negative organisms.  The 
response, as well as the type of signalling pathway, can also be affected by 
variability in the LPS core and the O-antigen (Jiang, Georgel, Du, Shamel et al., 
2005; Zughaier, Zimmer, Datta, Carlson et al., 2005).   
 
LPS from the cell walls of Gram-negative bacteria are potent inducers of the 
inflammatory response. Studies using natural and synthetic analogues of lipid A 
have demonstrated a direct relationship between the structures of lipid A and their 
cytokine-inducing capacities (Akamatsu, Fujimoto, Kataoka, Suda et al., 2006; 
Wang, Flad, Feist, Brade et al., 1991).  LPS biosynthesis underlies quantitative 
differences in the bacterial growth phases, which results in changes to the 
endotoxin content of the cells (Venter, Abraham, Lues & Ivanov, 2006).  It has 
been proven that for full expression of typical in vivo and in vitro endotoxic activity, 
a lipid A consisting of a ß-1,6-linked D-glucosamine disaccharide with two 
phosphate groups in position 1‟ and 4‟, substituted with 12 to 14 carbons in length, 
is required (Akamatsu et al., 2006; Dehus, Hartung & Hermann, 2006).  However, it 
must be noted that the LPS molecule itself is not toxic; it is the response of the host 
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cells to the LPS that renders it “poisonous” (Koyama, Sato, Nomura, Kubo et al. 
2000). 
 
 
5.2 CYTOKINES 
Cytokines are protein molecules, and their name was derived from early 
observations that these molecules influences cell (“cyto”) movement (“kinesis”).  
Cytokines, which control almost every aspect of the immune system, have 
molecular weights ranging between 8 and 80 kDa (Gesualdo, Pertosa, Grandaliano 
& Schena, 1998; Strouse, 2007) and do not freely cross the blood-brain barrier 
under normal circumstances (Maier & Watkins, 1998).  Interleukin-6 (IL-6) is a 
multifocal cytokine produced by lymphoid and non-lymphoid cells (Lee, Cho, Kang, 
Shin et al., 2004).  IL-6, an endogenous pyrogen, has been proven to regulate T- 
and B-cell functions and is able to induce acute-phase response proteins and 
maturation of megakaryocytes (Van Snick, 1990).  Pro-inflammatory cytokines, IL-
6, IL-1β and tumour necrosis factor-alpha, synthesised by activated macrophages 
and monocytes in response to an LPS challenge, are considered important 
mediators of sickness behaviour and fever (Harden, Du Plessis, Poole & Laburn, 
2006).  
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5.2.1 Methods To Assess Cytokines 
Various methods exist whereby the presence of cytokines is determined in various 
bodily fluids.  These methods are based on a sandwich enzyme-linked 
immunosorbent assays (ELISA) which was developed for the determination of 
human cytokines (Borg, Kristiansen, Christensen, Jepsen & Poulsen, 2002).  
However, swine presents with an important animal model for various diseases, and 
therefore porcine blood is increasingly being used for immunological investigations 
(Duvigneau, Sipos, Hartl, Bayer et al., 2007).  With this study, an alternative 
methodology is tested in which IL-6 expression in porcine whole blood, as opposed 
to human blood, challenged with LPS, is used as a biomarker for possible food-
borne pathogen toxicity.   
 
 
5.3 MATERIALS AND METHODS 
Refer to chapter 2 (sections 2.4.1 - 2.4.3;  p63-64) for materials and methods 
description on the propagation of the organisms, high pressure equipment and 
treatment, and to chapter 4 (section 4.5.1;  p124) for lipopolysaccharide extraction. 
 
 
5.3.1 Porcine Whole Blood Cell Culture Assay 
The method as proposed by Andrade, Silveira, Schmidt, Jùnior et al. (2003) for 
human whole blood was used.  Pooled porcine blood samples were processed 
within two hours of collection to minimise the undesired activation of cytokine 
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expression.  Porcine heparinised blood was diluted 1:3 with sterile saline.  Samples 
(with LPS) and endotoxin standard were added at 50 µl per microtitre well 
respectively.  Saline was added at 50 µl per well, and 150 µl per well of diluted 
whole blood were added to give a final volume of 250 µl.  The plates were 
incubated at 37 ºC for 16-24 hours in 5 % carbon dioxide (CO2) humid atmosphere.  
The cell supernatants were collected and assayed for IL-6 by porcine-specific 
immunoassay.   
 
 
5.3.2 Porcine Interleukin-6 Enzyme-Linked Immunosorbent Assay 
The serum concentration of interleukin-6 (IL-6) was determined using the 
Quantikine® Porcine IL-6 enzyme-linked immunosorbent assay (ELISA) (R & D 
Systems, White Sci, SA).  The methodology employs a quantitative sandwich 
enzyme immunoassay technique, and analysis was conducted as proposed by the 
manufacturer.  Standards, controls and samples were pipetted into the microtitre 
plate wells, and any porcine IL-6 present was bound by the immobilised antibody.  
After washing away any unbound substances, an enzyme-linked polyclonal 
antibody specific to porcine IL-6 was added to the wells.  Following a wash to 
remove any unbound antibody-enzyme reagent, a substrate was added to the 
wells.  The enzyme reaction yielded a blue product that turned yellow when the 
stop solution was added.  Readings were performed at 540 nm on a plate reader 
(Bio-Rad 680TM).  The intensity of the colour was measured in proportion to the 
amount of porcine IL-6 bound in the initial step.  Sample values were calculated 
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using the standard curve.  The correlation coefficient for the different kits varied 
between 0.723 and 0.998. 
 
 
5.4 RESULTS AND DISCUSSION 
The differences at unit time intervals between the test and control values were 
considered and presented as percentage difference (PD).  Refer to chapter 2 (p65-
66) for calculation of percentage difference.  A positive percentage value indicates 
that the IL-6 expression of the test organism (pressurised) was less than that of the 
control (non-pressurised), while a negative value indicates the opposite.  PDs 
lower than 200 were considered to be within experimental variability.  [Table 5.1 
shows an outline of the percentage differences].  
 
The ability to induce IL-6 in porcine whole blood, from cell-wall-bound (pellet) and 
free (supernatant) LPS from cultures of E. coli O111 subjected to HHP, was 
studied in vitro.  Porcine whole blood was challenged with LPS, and subsequent IL-
6 production by the cells was determined by a commercially available ELISA.  
E. coli O111 was subjected to sublethal HHP treatment, and recovery of 
pressurised cells was facilitated by incubation in buffered peptone water.  After 
exposure to HHP, it is to be expected that bacteria will be injured or killed, although 
this depends on the species and strain of the bacteria, the HHP treatment variables  
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Table 5.1 Percentage differences in IL-6 production induced by E. coli O111 
LPS observed for each of the treatment procedures (HHP at 200 MPa 15 min-1) 
 
  Percentage difference 
  
Treatment 
temp (ºC) 
0 H 6 H 18 H 24 H 30 H 48 H 
ST, OP 8
a
 -18 -4 0 -11 2 -3 
ST, AP 8
a
 -2 5 -2 -18 16 -5 
ST, OP 50
a
 1 -237 1034 7 -30 -9 
ST, AP 50
a
 0.5 -19 5 36 252 5 
        
PT, OP 8
a
 19 113 -49 23 -3 -10 
PT, AP 8
a
 6 -7 3 -242 14 20 
PT, OP 50
a
 -47 301 -10 904 64 156 
PT, AP 50
a
 -435 25 -196 82 202 -34 
        
ST, OP 8
b
 12 104 -43 15 8 12 
ST, AP 8
b
 -0.5 143 -23 4.5 -33 -9 
ST, OP 50
b
 168 -1 -1 -1.5 1 6 
ST, AP 50
b
 104 -5 9 118 12 -23 
        
PT, OP 8
b
 -21 -5 4 -2 0 -7367 
PT, AP 8
b
 75 -8 14 -22 -5 5 
PT, OP 50
b
 73 -8 -5 231 -2602 -45 
PT, AP 50
b
 23 1150 166 214 3 304 
ST - supernatant; PT – pellet; OP - organic phase; AP - aqueous phase; H - time (hours) 
(
a
) - low bacterial load;  (
b
) - high bacterial load 
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and the subsequent storage conditions.  Subsequent to injury, bacteria could  
regenerate during storage, which may have an effect on the microbiological quality 
of foodstuffs (Bozoğlu, Alpas & Kaletunç, 2004) – not only as an infectious agent, 
but as a toxic product as well.  E. coli O111 from the late exponential phase (after 
14-16 hours of incubation) were pressurised and immediately subcultured in fresh 
medium.  The exponential growth phase commenced after six hours (all cells) of 
incubation followed by the stationary phase at 48 hours.  
 
Decreased toxicity (positive PDs) was observed in the following instances:  
50ºCa & b, PT, AP at the lag and late stationary phases;  8ºCa and 50ºCa, PT, OP at 
the lag and exponential phases;  50ºCa & b, ST, AP at the early and mid-stationary 
phases and 8ºCa & b, ST, AP at the lag phase.  
 
It is possible that sublethal HHP damage resulted in lipid A monomers that were 
not detected by the leukocytes, resulting in the negative PDs observed.  Structural 
repair resulting in dephosphorylated LPS could lead to non-activation of the 
leukocytes.  Should partial LPS be present in either pentaacyl or tetraacyl 
conformation, this would lead to reduced toxicity.  LPS structures present in the 
cylindrical shape could also have resulted in lower toxicity and inability to produce 
IL-6.  The formation of lamellar aggregate structures could also result in lower 
toxicity, as observed with the pressurised cells.  HHP in these instances resulted in 
decreased production of IL-6 by the pressurised cells, indicating the effect that 
various structural changes may have on the ability of the LPS to challenge porcine 
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whole blood for IL-6 expression.  
 
Increased toxicity (negative PDs) was observed in the following instances:  8ºCa & b, 
PT, AP at the early stationary phase;  8ºCb and 50ºCb, PT, OP at the late stationary 
phase;  8ºCb and 50ºCb, ST, AP at the lag phase and 8ºCa and 50ºCa, ST, AP at 
the lag and exponential phases.  
 
Variations in IL-6 expression, as seen from the results, are a function of the 
physiological status of the cell in response to sublethal HHP and cell death.  In 
instances where negative PDs were observed, it can be assumed that the lipid A 
structure was able to stimulate the release of IL-6 from porcine whole blood.  LPS 
present with two phosphate groups and six acyl chains (Brandenburg, Andrä, 
Müller, Koch & Garidel, 2003) will constitute the optimal LPS structure, resulting in 
the higher toxicity observed in these instances.  LPS structures present in the 
conical shape are optimal for Toll-like receptor 4 (TLR4) activation (increased 
toxicity) resulting in increased IL-6 production.  The presence of cubic inverted 
aggregate structures of the LPS could also constitute higher toxic activity, thus 
increasing IL-6 production.   
 
In this study, a PD of -435 was observed for 50a, PT, AP (immediately after 
pressurisation).  This could be explained by a higher structurally altered (in 
response to HHP stress) polysaccharide portion in the aqueous phase, resulting in 
increased toxicity.  The increased toxicity observed in the aqueous phase supports 
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the findings of Abraham, Venter, Lues, Ivanov & de Smidt (2009) who proved that 
toxicity is not only influenced by lipid A but also by changes in the O-chain in 
response to structural stress adaptations. 
 
The PDs observed with the 8 ºC treatment parameters were generally lower than 
those observed for the 50 ºC treatment parameters.  Differences in IL-6 expression 
were still eminent up to the late stationary phase, indicating a higher LPS content 
in the organic phase.  Overall, it would appear that HHP resulted in LPS being less 
able to stimulate IL-6 production [See figure 5.1 for an illustration of a typical 
bacterial growth curve and the related toxicity observed in each of the phases].   
 
It is evident that HHP had an effect on LPS structure as variances in IL-6 
expression between the two phases were observed, thus the quantity of the LPS 
does not correlate with the toxicity.  It is therefore advisable that for example the 
pharmaceutical industry must not only consider LPS toxicity in terms of quantity but 
also evaluate toxicity qualitatively.  Further research into the use of whole blood 
porcine IL-6 production could prove beneficial for both the food and pharmaceutical 
industries.   
 
This novel test could parallel with human whole blood culture test systems to 
evaluate the pyrogenicity of different matrixes.  However, the response of porcine 
whole blood to LPS-induced IL-6 expression does not exactly mimic the human in  
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Symbols below the line indicate higher toxicity whereas symbols above the line indicate lower 
toxicity, as observed for the different bacterial growth phases.  (
a
)–low bacterial load;  (
b
)–high 
bacterial load;  PT=pellet;  ST=supernatant;  OP=organic phase;  AP=aqueous phase;  1=lag 
phase;  2=exponential phase;  3=early stationary phase;  4=mid-stationary phase;  5=late stationary 
phase.   
 
Figure 5.1 Illustration of a typical bacterial growth curve and the related toxicity 
observed in each of the phases.  
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vivo response to IL-6 production.  There is also the need to quantify the efficacy of 
the IL-6 porcine whole blood test system against other Gram-negative bacteria, 
Gram-positive bacteria, viruses, fungi and yeasts.  The use of fresh blood does, 
unfortunately, have certain limitations e.g. there may be limited amounts of porcine 
blood available from a single donor, hence the need to use pooled blood.  
Research into the use of pooled cryopreserved porcine blood for IL-6 
determinations may address the limitations and may result in a cost-effective 
alternative to the LAL.  Similar to LAL, the results from the IL-6 assay also proved 
that HHP had an effect on the structure of LPS which influenced toxicity.  The 
quality and quantity of LPS in this instance had an influence on the ability of whole 
porcine blood (after being challenged with LPS) to express IL-6. 
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6. EVALUATION OF AN IN VITRO PYROGEN ASSAY BASED ON 
THE EXPRESSION OF IL-6 FROM PORCINE WHOLE BLOOD:  
COMPARISON WITH THE LIMULUS AMEBOCYTE LYSATE 
 
6.1 LIMULUS AMEBOCYTE LYSATE 
LPS forms a major component of the outer membrane of Gram negative bacteria 
(Caroff, Karibian, Cavaillon, & Haeffner-Cavaillon, 2002).  It is unique and highly 
conserved bacterial surface molecules that engage with the innate immune system 
of the host via pattern recognition receptors on a range of host cells (Hodgson, 
2006).  The LAL is a common method used for endotoxin measurement and is 
based on the initiation of the coagulation cascade in the LAL (Tanaka and 
Iwanaga, 1993). 
 
The LAL assay is used as an in vitro end-product endotoxin test for human and 
animal parenteral drugs, biological products and medical devices.  It is however 
advised that this product is not intended for in vitro determination of endotoxemia in 
human (Cambrex).  The test procedures are based on those described in the 
United States (U.S.) Food and Drug Administration (FDA) guidelines whereby it 1) 
established endotoxin limits for pharmaceuticals and medical devices, 2) validated 
the use of LAL as an end-product endotoxin test, and 3) developed a routine 
testing protocol (U.S. Department of Health and Human Services, FDA).   
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Even though the LAL is the assay of choice to determine endotoxin, it is known that 
numerous factors do however influence final outcome of the LAL assay, and it 
does not exactly parallel in vivo pyrogenic activity (Lee, Sung, Han, Lee et al., 
2005).  Even though the LAL is highly sensitive, it is not able to detect non-
endotoxin pyrogens (Hoffmann, Peterbauer, Schindler, Fenrich, et al., 2005) and it 
also reacts with 1,3-ß-glucans of fungi (Iwanaga, 1993).  Furthermore it is not 
possible to obtain a reliable and repeatable estimate of endotoxin in serum and 
plasma samples since the reaction of endotoxin with LAL is susceptible to either 
inhibition or enhancement due to contamination with fungal beta glucans or factors 
present in blood (Hausmann, Yulzari, Lewis, Saisky, & Douvdevani, 2000;  
Hodgson, 2006).  The chemical and physiochemical structure of endotoxin also 
influences the LAL reaction (Rietschel, Brade, Brade, Brandenburg, 1987;  
Abraham, Venter, Lues, Ivanov, & de Smidt, 2009).   
 
The LAL assay is generally based on the bacterial endotoxin catalyzing the 
activation of a proenzyme in the LAL (Young, Levin & Prendergast, 1972).  The 
initial rate of activation is determined by the endotoxin concentration and structure.  
The activated enzyme catalyzes the removal of pNA from a colorless substrate Ac-
Lle-Glu-Ala-Arg-pNa.  pNA released is measured photometrically at 405-410 nm 
after the stop reagent is added.  The correlation between the absorbance and 
endotoxin concentration is said to be linear in the 0.1-1.0 EU ml-1 range.  Endotoxin 
concentration is then calculated from the absorbance values of solutions containing 
known amounts of endotoxin standard (R&D Systems). 
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6.2 PORCINE IL-6 
Cytokines regulate the cellular immune response and are produced by a variety of 
cells, notably monocytes, lymphocytes and macrophages.  Therefore the presence 
of cytokines usually yields useful information on the pathological processes of 
various diseases such as sepsis, cancer, endotoxic shock and acquired immuno 
deficiency syndrome (Molina, Gamboa, Benavides, León, Guerra, & Padilla, 2006).  
Interleukin-6 is an example of a pleiotropic cytokine that regulates the immune 
response, acute phase reaction, and hematopoiesis (Scamurra, Arriaga, Sprunger, 
Baarsch, & Murtaugh, 1996).   
 
Typically IL-6 is measured in plasma and serum by means of a human enzyme 
linked immunosorbent assay (ELISA) (van Leeuwen, Westra, Limburg, van Riel & 
van Rijswijk, 1995) or the Luminex analysis (Hergenroeder, Moore, McCoy, 
Samsel et al., 2010).  The Quantikine® porcine IL-6 immunoassay is a solid phase 
ELISA intended to measure porcine IL-6 in cell culture supernates, serum and 
plasma.  It contains E. coli-expressed recombinant porcine IL-6 in addition to 
antibodies raised against the recombinant factor.  This assay is able to quantitate 
recombinant porcine IL-6 and can also be used to determine the relative quantity of 
for natural porcine IL-6 (R&D Systems). 
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6.3 MATERIALS AND METHODS 
6.3.1 Limulus Amoebocyte Lysate Assay  
Refer to materials and methods in chapter 4 (section 4.5.2:  p125) for a description 
on the methodology of the LAL assay.  
 
 
6.3.2 Porcine Whole Blood Cell Culture Assay 
Refer to material and methods in chapter 5 (section 5.3.1:  p145) for a description 
on the methodology of whole blood challenge with LPS. 
 
 
6.3.3 Porcine Interleukin-6 ELISA 
Refer to material and methods in chapter 5 (section 5.3.2:  p147) for a description 
on the methodology of the Porcine ELISA. 
   
 
6.4 RESULTS AND DISCUSSION 
6.4.1 IL-6 Expression After Challenge With LPS Containing Samples 
Samples and endotoxin standards at a concentration of 1 EU were used to 
stimulate heparinized porcine whole blood for IL-6 expression.  For the porcine IL-6 
it is indicated that within the parameters of intra-assay and inter-assay precision 
the maximum coefficient of variation (C.V.) was 10%.  Within the parameters of this 
study, the average C.V. observed for all the standards assayed in the 8 microtitre 
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plates was 4.3 (concentrations of the standard dilutions from which the calibration 
curve were drawn:  2 500, 1250, 625, 312, 156, 78.1 and 39.1 picogram).  The 
optimum C.V. for the LAL should be less than 10%.  Within the parameters of this 
study, average C.V. observed for all the standards assayed in the 8 microtitre 
plates was 9.1 (endotoxin units of the standard from which the calibration curve 
were drawn:  1.0, 0.5, 0.25 and 0.1).  [See table 6.1 for instances where picogram 
amounts of IL-6 were detected (not extrapolating below the lowest standard which 
is 39.1 pg ml-1) in the test samples and compared with the corresponding LAL 
values (endotoxin units)]. 
 
Dehus, Hartung & Hermann (2006) reported that in human whole blood a 1 000 
times more LPS from Pseudomonas aeruginosa was necessary to induce IL-6 
expression in amounts comparable to LPS from enterobacteriaceae (e.g. LPS 
10 ng ml-1 from Salmonella abortus equi 46 ± 5.3 ng ml-1 IL-6 vs. LPS 10 µg ml-1 
from Pseudomonas aeruginosa 55 ± 6.3 ng ml-1 IL-6).  From the results it is 
observed that in this study there is no correlation between the IL-6 value measured 
and that of the LAL value in any of the treatment parameters.  These results concur 
with those of Dehus et al., (2006) whereby the whole blood assay does not always 
correlate with the Limulus test. 
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Table 6.1:  Values for porcine IL-6 and LAL obtained from selected treatment 
parameters 
 
Hours 
 
Treatment parameter  
 
IL-6 concentration  
(pg ml
-1
) 
 
LAL (EU ml
-1
) 
 
0 
6 
 
18 
24 
 
30 
 
48 
 
0 
24 
 
 
18 
 
6 
 
24 
 
T50ºC
a
, PT, AP 
T50ºC
a
, PT, OP 
T50ºC
a
, PT, AP 
T50ºC
a
, PT, AP 
T50ºC
a
, PT, OP 
T50ºCa, PT, AP 
T50ºC
a
, PT, OP 
T50ºC
a
, PT, AP 
T50ºC
a
, PT, OP 
 
T50ºC
b
, PT, OP 
T50ºC
b
, PT, OP  
T50ºC
b
, PT, AP  
 
T50ºC
a
, ST, OP 
 
T8ºC
b
, ST, AP 
 
T50ºC
b
, ST, AP 
 
0.16 
960 
396 
203 
974 
51.5 
1760 
698 
364 
 
0.08 
1568 
2912 
 
819 
 
1184 
 
814 
 
0.007 
3 
7 
14 
-1 
12 
6 
7 
-0.13 
 
0.005 
3.7 
0.09 
 
-0.07 
 
-0.78 
 
15 
T – test;  ST - supernatant;  PT - pellet:  OP - organic phase;  AP - aqueous phase;   
(
a
) - low bacterial load;  (
b
) - high bacterial load 
 
 
6.4.2 Additional Materials And Equipment Required 
In addition to the material supplied in the test kits (LAL and IL-6), additional 
materials and equipment are also needed to perform the analysis.  Before the IL-6 
ELISA can be performed there is also the additional procedure of collecting blood 
from swine and challenging the porcine whole blood with the LPS containing 
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samples.  [See table 6.2 for a summary of the additional materials and equipment 
(not supplied in the test kits) needed for the LAL assay, the IL-6 ELISA and the 
LPS challenge of the porcine whole blood]. 
 
 
Table 6.2 Additional materials and equipment needed for the LAL and IL-6 
 
 
Additional materials and equipment for 
LAL 
 
Additional materials and equipment for IL-6 
 
Microplate reader 
Automatic- and 8 channel pipettes and 
pyrogen free tips 
LAL reagent water 
Stopwatch 
Endotoxin free glass tubes 
Vortex mixer 
Multi-Blok heater 
Reagent reservoirs 
Pyrogen free microplates 
Acetic acid stop reagent (25% v/v) 
0.1 N Sodium hydroxide  
0.1N Hydrochloric acid 
 
Microplate reader 
Automatic- and 8 channel pipettes and pyrogen 
free tips 
Pyrogen free water 
Stopwatch 
Additional materials and equipment for LPS 
challenge 
Heparinized vacutainer
®
 tubes 
15 Gauge needle 
Holder/adapter 
Alcohol wipes 
Needle disposal unit 
Gloves 
Container for transport of blood to laboratory 
Pyrogen free glass container for preparation of 
pooled blood 
Sterile, pyrogen free saline 
Pyrogen free microplates 
Carbon dioxide (CO
2
) incubator 
 
 
As both test kits in this instance was used to detect LPS, care must be taken at all 
times only to use pyrogen free equipment and -water.  Performing the porcine the 
IL-6 is a lengthy process when compared to the LAL.  [See table 6.3 for a 
comparison of the estimated turn around times (TAT) for LAL and IL-6].  
Furthermore, the supernates needs to be carefully pipetted from the microwells into 
the precoated IL-6 ELISA kit wells not to disturb and transfer any blood products 
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which could interfere with the analysis.  The IL-6 ELISA still requires products from 
animal origin (ethical considerations) and there is a need for a skilled animal 
phlebotomist to collect the blood in a sterile manner in order to avoid contamination 
from organic dust from the environment which could lead to false activation of the 
mononuclear cells by LPS in the dust.  It must also be determined before 
 
 
Table 6.3 Estimated turn around times for LAL and IL-6 
 
 
Estimated TAT for LAL 
 
Estimated TAT for IL-6 
 
Procedure 
 
Approximate 
time (hours) 
 
Procedure 
 
Approximate 
time (hours) 
 
Preparation of reagents, 
standards and controls 
 
1 
 
Preparation of reagents, 
standards and controls 
 
0.5 
Wash and incubation steps 0.25 Collection, transport and 
processing of blood  
4 
  Incubation process (LPS 
challenge of blood) 
16-24 
  Wash and incubation steps 4.5 
Total 1.25  25-33 
 
 
hand when swine will be available, thus scheduling and coordination between the 
laboratory personnel and the animal phlebotomist must be taken into 
consideration.  The animal phlebotomist must also be trained in handling of the 
specimens, since to much manipulation and incorrect storage of the blood 
specimens can result in undesired stimulation of the cytokine expression pattern, 
resulting in false positive values.  The use of whole blood has the advantage of 
fewer ex vivo manipulations compared to the use of mononuclear cell preparations, 
thereby reducing the accumulation of undesired stimulatory effects (Duvigneau, 
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Hartl, Teinfalt & Gemeiner 2003).  If animal facilities are not situated in close 
proximity to the laboratory, this will result in delay in processing of the samples.  
Porcine blood should be processed within 2 hours to prevent undesired stimulatory 
effects on the cytokine expression pattern.  Collection, transport, dilution of blood 
(cell preparation) and overnight incubation, therefore makes the IL-6 ELISA test 
laborious and time consuming.  In a laboratory where emphasis is on a fast turn 
around time (TAT) and high volume work load this methodology is to time 
consuming and laborious.  Advantages however are that the porcine IL-6 will also 
detect non lipopolysaccharide pyrogens, it can thus be used to determine the 
presence of Gram positive contaminants as well. 
 
Even though the LAL is not the ideal test, it remains the method of choice for the 
detection of LPS in parenteral drugs and food substrates.  The availability of 
cryopreserved porcine blood purchased as part of the porcine IL-6 ELISA kit would 
render this test more favorable.  The cost of implementing the porcine IL-6 as a 
routine test would however be high.  The use of the porcine IL-6 also needs to be 
validated and standardized against other in vitro test systems using human blood.  
These validation tests should not only be performed on laboratory media but 
should include actual high hydrostatic pressure treated food substrates.  As 
mentioned by de Boer and Beumer (1999) the sample matrix could influence the 
results whereby background biota, natural substances or debris can interfere with 
the test method and invalidate the test results.  Furthermore the potency of post 
HHP treated E. coli O111 LPS to induce IL-6 and correlation with endotoxin 
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concentration needs to be investigated.  It can be concluded that within the 
parameters of this study, no correlation between IL-6 expression in porcine whole 
blood (after LPS challenge) and the LAL assay can be made.  This however does 
not negate the use of the porcine IL-6 assay as further research and development 
could lead to the successful implementation of this test methodology for the 
detection of pyrogenic contaminants in matrixes such as medical products 
(parenteral drugs) or equipment, the detection of pyrogens in organic dust 
samples, or the implementation thereof as an alternative to the LAL. 
 
 
 
 174 
6.5 REFERENCES 
Abraham, M., Venter, P., Lues, J.F.R., Ivanov, I. & de Smidt, O. 2009.  Influence of 
selected antimicrobials on the viability, endotoxicity and lipopolysaccharide 
composition of Pseudomonas aeruginosa in vitro.  International Journal of 
Antimicrobial Agents, 34(5): 419-423. 
 
Andrade S.S., Silveira R.L, Schmidt C.A, Jùnior L.B & Dalmora S.L. 2003.  
Comparative evaluation of the human whole blood and human peripheral blood 
monocyte tests for pyrogens.  International Journal of Pharmaceutics, 265: 115-
124. 
 
Cambrex, Limulus Amebocyte Lysate (LAL) QCL-1000®, Catalog Number:50-648U 
package insert 
 
Caroff, M., Karibian, D., Cavaillon, J-M. & Haeffner-Cavaillon, N. 2002.  Structural 
and functional analyses of bacterial lipopolysaccharides.  Microbes and Infection, 
4: 915-926.  
 
De Boer, E & Beumer, R.R. 1999.  Methodology for detection and typing of 
foodborne microorganisms.  International Journal of Food Microbiology, 50: 119-
130. 
 
 175 
Dehus, O., Hartung, T. & Hermann, C. 2006.  Endotoxin evaluation of eleven 
lipopolysaccharides by whole blood assay does not always correlate with Limulus 
amebocyte lysate assay.  Journal of Endotoxin Research, 12(3): 171-180. 
 
Duvigneau, J.C., Hartl, R.T., Teinfalt, M & Gemeiner, M. 2003.  Delay in processing 
porcine whole blood affects cytokine expression.  Journal of Immunological 
Methods, 272: 11-21. 
 
Hausmann, M.J., Yulzari, R., Lewis, E., Saisky, Y. & Douvdevani, A. 2000.  Gel clot 
LAL assay in the initial management of peritoneal dialysis patients with peritonitis: 
a retrospective study.  Nephrology, dialysis, transplantation, 15: 680-683. 
 
Hergenroeder, G.W., Moore, A.N., McCoy, J.P., Samsel, L., Ward, N.H., Clifton, 
G.L. & Dash, P.K. 2010.  Serum IL-6: a candidate biomarker for intracranial 
pressure elevation following isolated traumatic brain injury.  Journal of 
Neuroinflammation, 7(19): 1-13. 
 
Hodgson, J.C. 2006.  Endotoxin and mammalian host responses during 
experimental disease.  Journal of Comparative Pathology, 135: 157-175. 
 
Hoffmann, S., Peterbauer, A., Schindler, S., Fenrich, S., Poole, S., Mistry, Y., 
Montag-Lessing T., et al. 2005.  International validation of novel pyrogen tests 
 176 
based on human monocytoid cell lines.  Journal of Immunological methods, 298: 
161-173. 
 
Iwanaga, S. 1993.  The limulus clotting reaction.  Current Opinion in Immunology, 
5: 74-82. 
 
Lee, D.H., Sung, H-J., Han, D-W., Lee, M-S., Ryu, G.H., Aihara, M., Takatori, K. & 
Park, J-C. 2005.  In vitro bioassay of endotoxin using fluorescein as a pH indicator 
in a macrophage cell culture system.  Yonsei Medical Journal, 46 (2): 268-274. 
 
Molina, M.A., Gamboa, E.M., Benavides, P.Z., León, L.C., Guerra, R.T. & Padilla, 
C.R. 2006.  Spontaneous inflammatory cytokine gene expression in normal human 
peripheral blood mononuclear cells.  Lymphatic Research and Biology, 4(1): 34-40. 
 
R&D Systems, Quantikine®, Porcine IL-6, catalog Number P6000 package insert. 
 
Rietschel, E.T., Brade, H., Brade, L., Brandenburg, K., Schade, U., Seydel, U., 
Zähringer, U., Galanos, C., Lüderitz, O., Westphal, O., et al., 1987.  Lipid A, the 
endotoxic center of bacterial lipopolysaccharides: relation of chemical structure to 
biological activity.  Progress in Clinical and Biological Research, 231: 25-53. 
 
Scamurra, R.W., Arriaga, C., Sprunger, L., Baarsch, M.J. & Murtaugh, M.P. 1996.  
 177 
Regulation of interleukin-6 expression in porcine immune cells.  Journal of 
Interferon & Cytokine Research, 16(4): 289-296. 
 
Second supplement to USP 24-NF19. <85> Bacterial Endotoxins.  Rockville, MD: 
United States Pharmacopeia, 2000, 2875-2879. 
 
Tanaka, S. & Iwanaga, S. 1993.  Limulus test for detecting bacterial endotoxins.  
Methods in Enzymology, 223: 358-364. 
 
United States Department of Health and Human Services, Public Health Service, 
Food and Drug Administration “Guideline on Validation of the Limulus Amebocyte 
Lysate tests as an End-product Endotoxin Test for Human and Animal Parenteral 
drugs, Biological Products, and Medical Devices”, 1987. 
 
van Leeuwen, M.A., Westra, J., Limburg, P.C. van Riel, P.L. & van Rijswijk, M.H. 
1995.  Clinical significance of interleukin-6 measurement in early rheumatoid 
arthritis:  relation with laboratory and clinical variables and radiological progression 
in a three year prospective study.   
 
Young, N.S., Levin, J. & Prendergast, R.A. 1972.  An invertebrate coagulation 
system activated by endotoxin:  Evidence for enzymatic mechanism.  Journal of 
Clinical Investigation, 51: 1790-1797.  Annals of the Rheumatic Diseases, 54: 674-
 178 
677. 
 
 
 179 
 
 
 
 
CHAPTER 7 
 
 
 
 
 
 
 
 
 180 
7. CONCLUDING REMARKS 
7.1 BACKGROUND 
For many years, improvement in food production and preservation technologies 
have contributed to food safety systems and in most developed countries was 
perceived by many to be efficient in the prevention of food borne disease.  Food 
borne diseases can result in severe illness in the young, old and the 
immunocompromised.  Numerous problems are prevailing, one of these being the 
high level of food borne microbiological diseases which seem, for some pathogens, 
to have increased over the last decades.  This has led to the development of 
alternative technologies to the conventional preservation methods.  High 
hydrostatic pressure (HHP) is one of these alternative methods of food 
preservation that involves the application of high pressure to achieve microbial 
inactivation without changing the organoleptic characteristics of food.  The 
numerous applications of HHP in the food industry reflect the success story of this 
preservation technology.  Although there are certain limitations to its application, it 
is still considered as a favorable alternative to traditional thermal processing.  First 
considered in the food industry for its worth in the inactivation of micro-organisms, 
it has now proved its value in other areas of food processing.  E.g. it was found that 
pressures of around 200 MPa is sufficient to shuck oysters, thereby reducing the 
laborious process of hand shucking.  Developments in the sphere of HHP have led 
to the implementation of hurdle treatment regimes, whereby not only time-
temperature-pressure are the only variables, but where the use of e.g. bacteriocins 
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and antibiotics, and the manipulation of pH and salt concentration augmented the 
effect of HHP as a food preservation technology. 
 
 
7.2 SUMMARISED PROCEDURES 
Three bacterial strains, known for their pathogenicity in the food industry, were 
selected for pressurisation studies.  These organisms, Escherichia coli O111, 
Staphylococcus aureus ATCC 25923 and Listeria monocytogenes (UAFSBCC), 
were subjected to 200 MPa pressure at temperatures of 8 ºC and 50 ºC 
respectively for 15 minutes.  Different enumeration methods were used to assess 
cell damage and evaluate the growth phases of the surviving cells in order to shed 
light on subsequent cellular repair after sub-lethal injury.  The influence of sublethal 
HHP on the liberation and toxicity of bacterial endotoxins (free and cell wall bound) 
was assessed by means of the LAL, and a porcine IL-6 ELISA assay was 
evaluated as an alternative for the customary LAL as a biomarker for pyrogenic 
substances in matrixes.  The use of the chloroform:methanol LPS extraction 
(chapter 4), is a novel method whereby differences in toxicity (structural 
adaptations in response to HHP stress) in organic and aqueous phases was 
determined.   
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7.3 ORGANISM SUSCEPTIBILITY TO HHP  
Staphylococcus aureus (chapter 3) proved to be the most resistant organism and 
E. coli proved to be the most sensitive (chapter 2).  The selection of the most 
resistant strain as a parameter for optimum microbial inactivation is essential 
whereby sub-lethally injured bacteria can pose a bona fide hazard in the food 
processing industry as they are able to repair and proliferate under favorable 
conditions, leading to spoilage of the food matrix.  The survival of injured cells are 
influenced by various factors such as selection of recovery medium for bacterial 
cultivation (enriched medium vs. selective medium), and storage conditions 
(refrigeration vs. on shelf storage of the product) (chapter 2 & 3).  Bacterial 
concentration (chapter 2) in the matrix will also determine the magnitude and 
duration of the HHP treatment as it was proven that the inactivation rate and 
bacterial concentration are inversely proportionate to each other.  This study was 
performed under laboratory conditions whereby the pathogens and substrate were 
controlled.  When extrapolating data to other matrixes it must be taken into 
consideration that e.g. a high protein environment (as found in oysters) could 
contribute to the baro-resistance of bacteria in the matrix.  
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7.4 EFFECT OF HHP ON LPS TOXICITY 
It is well known that endotoxins are a product of Gram-negative bacteria, hence the 
preference for E. coli O111 to perform toxicity studies (chapter 4).  It was observed 
that HHP had an influence in the overall toxicity (as measured by the LAL) of 
E. coli O111 measured after only 6 hours of incubation for most of the treatment 
parameters.  In view of these results, not only will the pressurised product still be 
contaminated with bacteria (chapter 2), but it will result in a more toxic product.  
This change in toxicity could be the result of structural outer membrane 
adaptations in response to HHP and temperature stressors (hurdles).  It can thus 
be reasoned that even though Listeria monocytogenes is able to produce an 
endotoxin-like substance in its cell wall, toxicity will be less than that observed for 
E. coli O111 as Listeria monocytogenes is known to be more resistant to HHP 
stress than E. coli O111.   
 
LPS structural membrane adaptation caused by HHP could also influence the 
response of the immune system to LPS.  From the results (chapter 5) it is evident 
that sublethal HHP cellular damage and LPS structural changes 
(dephosphorylation and lipid A monomers) could influence the ability of LPS to 
stimulate leukocytes to produce IL-6.  As observed with the LAL, it is evident that 
HHP had an effect on LPS structure, in this instance LPS was less able to 
stimulate IL-6 production.  However, no correlation between the LAL activity and 
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porcine IL-6 expression could be made due to the structural orientation of the LPS, 
and different binding sites and modes of activation of the LAL and IL-6 expression.   
 
 
7.5 OTHER APPLICATIONS OF HHP 
The advancement of HHP technology requires knowledge from many fields of 
study, from mathematics, physics, biology, chemistry, engineering, aquaculture, 
agriculture to medicine.  Advantages to the food industry and consumer alike are 
the minimum change in organoleptical- and nutritional quality of a safer food 
product with an extended shelf life.  Other applications of HHP could include the 
sterilization of starter cultures (e.g. in the cheese making process) whereby any 
bacteriophage contaminants could be inactivated whilst leaving the Lactobacilli 
active.  In cases where microbiological culture media are prepared in bulk for 
shipment to smaller satellite laboratories, there is always the possibility of bacterial, 
viral and fungal contamination of the media.  HHP could therefore be employed in 
the sterilization of especially heat sensitive microbiological culture media.   
 
In July 1988 the UK banned the use of ruminant proteins in the preparation of 
animal feed due to the presence of a highly stable, heat, freeze and drying 
resistant agent.  This agent, although it is still uncertain whether it is a prion 
(misfolded protein) or a virus-like agent, is the cause of bovine spongiform 
encephalopathy, a disease affecting both humans (Creutzfeldt-Jakob disease) and 
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animals (mad-cow disease) (WHO, 2002).  This disease was also transmitted 
through the use of vaccines prepared from pooled sheep brains, spinal cords, and 
spleens (Giles, Glidden, Beckwith, Seoanes, Peretz, DeArmond & Prusiner, 2008).  
As it has been proven that HHP effectively inactivate prions and viruses, the use of 
HHP to decontaminate carcasses will not only inactivate bacterial contaminants, 
but could also be successful in inactivating any prions and viruses.  This would 
render a product which could again be used in the production of animal feed.  This 
application could be extended for the sterilization of heat and irradiation sensitive 
vaccines and biopharmaceuticals.  The effect HHP have on the folding and 
unfolding of proteins could be exploited for the preparation of various vaccines.  
The use of HHP in the medical field is reaching far beyond than would be expected 
from a food preservation technology.  Knowledge on the effect of high hydrostatic 
pressure on living cells (in vitro and in vivo), could revolutionize the current 
application of HHP in the medical field whereby ex vivo inactivation of pathogens in 
blood products could also be the norm rather than the exception.   
 
 
7.6 FUTURE RESEARCH 
As this study only evaluated the influence of sub lethal high hydrostatic pressure 
on bacterial cell viability, repair, and the influence on toxicity, the following aspects 
could be prospects for future research: 
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1. The influence of metabolic adaptation and cellular repair on the 
lipopolysaccharide structure of Gram-negative organisms and the 
lipoteichoic acid (LTA) structure of Gram positive organisms needs further 
clarification.  GC-MS analysis of 3-hydroxy fatty acids could provide 
valuable information on the LPS profile in the extractions when performing a 
risk analysis on food preserved with HHP. 
2. The relationship between the LPS structure and toxicity of post HHP E. coli 
O111 also needs further investigation.   
3. The influence HHP may have on the enzymes responsible for Kdo 
biosyntheses and membrane structure. 
4. A study on the liberation of endotoxins and pyrogens post HHP needs to be 
performed on organisms in actual food matrixes. 
5. The efficacy of the IL-6 porcine whole blood assay needs to be validated 
and standardized against the human whole blood IL-6 assay. 
6. The establishment of cryopreserved porcine blood pool for IL-6 
determinations. 
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